Palladium-Catalyzed Vicinal Amino Alcohols Synthesis from Allyl Amines by In Situ Tether Formation and Carboetherification by Orcel, Ugo & Waser, Jerome
  
1 
Synthetic Methods DOI: 10.1002/anie.201((will be filled in by the editorial staff)) 
Pd-Catalyzed Vicinal Amino Alcohols Synthesis from Allyl Amines 
via in Situ Tether Formation and Carboetherification** 
Ugo Orcel and Jerome Waser * 
((optional))
Abstract: Vicinal amino alcohols are important structural motifs of 
bioactive compounds. Herein, we report an efficient method for 
their synthesis based on the palladium-catalyzed oxy- alkynylation, 
arylation or vinylation of allylic amines. High regio- and 
stereoselectivity were ensured through the in situ formation of a 
hemiaminal tether using the cheap commercially available 
trifluoroacetaldehyde in its hemiacetal form. The obtained 
compounds are important building blocks, which can be 
orthogonally deprotected to give either free alcohols, amines or 
terminal alkynes. 
 
Vicinal amino alcohols are highly important structural motifs 
found in bioactive compounds such as the drug Tamiflu (1) or the 
natural product AI-77-B (2)[1] (Scheme 1, A). They have also been 
broadly applied as chiral ligands and auxiliaries. Therefore, there is 
a strong interest in the development of new methods to access them. 
Two of the most common synthetic approaches are the ring-opening 
of epoxides or aziridines and the metal-catalyzed 
aminohydroxylation of alkenes (Scheme 1, B).[2] Although 
straightforward, these methods are often plagued by regioselectivity 
issues.[2b] The use of tethers has emerged as a viable strategy to 
achieve better selectivity and reactivity in organic synthesis.[3] 
However, this method often lacks efficiency as extra steps are 
required for tether introduction and removal. Regarding the 
synthesis of vicinal amino alcohols, allyl amines are particularly 
attractive starting materials: numerous methods are available for 
their synthesis and the high nucleophilicity of nitrogen should allow 
the in situ formation of a hemiaminal tether by reaction with an 
aldehyde. Amino alcohol synthesis could be accompanied by the 
introduction of a second functional group onto the alkene allowing a 
maximal increase in molecular complexity (Scheme 1, B). The 
formation of a valuable C-C bond would be especially interesting, 
yet more challenging than the introduction of a second 
heteroatom.[4] Concerning the multi-functionalization of unactivated 
olefins, palladium catalysis has been highly successful in the last 
decades,[5] but has not yet been applied to the outlined strategy.[6] 
Precedence for the projected in situ formation of a hemiaminal 
tether using allyl amines and aldehydes can be found in the elegant 
metal-free approach developed by Beauchemin and co-workers for 
the cope-type hydroamination of allylic amines (Scheme 2, A).[7] 
However, the use of an aldehyde as tether has never been reported 
for the Pd-catalyzed multi-functionalization of olefins. Even in the 
broader field of palladium catalysis, the potential of this approach 
has been only scarcely explored. Menche and co-workers developed 
an elegant synthesis of 1,3-diols via a domino acetal-
formation/Tsuji-Trost reaction starting from homo-allylic 
alcohols.[8]  Hiemstra and co-workers, and more recently Stahl and 
co-workers, reported the use of hemiaminals for the Wacker 
cyclization reaction starting from allyl amines and alcohols, but the 
diastereoselectivity was low for the former and an additional step 
was needed to install the tether for both methods.[9] 
 
 
Scheme 1. Importance and synthesis of vicinal amino alcohols. 
Based on this precedence and our interest in olefin oxy- and 
aminoalkynylation,[10] we demonstrate herein that 
trifluoroacetaldehyde used as its cheap hemiacetal form 3 enables 
the Pd-catalyzed carbo-oxygenation of allyl amines through a one-
pot tethered process. In this transformation, amino alcohols are 
successfully formed with the concomitant introduction of alkynyl, 
aryl or vinyl groups (Scheme 2, B). This versatile strategy combines 
key advantages of both intramolecular and intermolecular reactions: 
high reactivity, stereo-, regio- and diastereoselectivity, as well as the 
use of simple starting materials.  
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Scheme 2. The tether strategy for allyl amine functionalization. 
In order to develop a one-pot tethered synthesis of amino 
alcohols starting from allyl amines, it is first important to analyze 
the key parameters for success of this challenging process (Scheme 
3). First, the allyl amine starting materials could react directly with 
palladium, leading to catalyst deactivation or side reactions such as 
Heck coupling and Buchwald-Hartwig type C-N bond formation. To 
avoid these pitfalls, formation of the hemiaminal intermediate I 
should be both fast and thermodynamically favored. Second, 
formation of a reactive iminium intermediate II should be avoided, 
as it can lead to unproductive aminal formation with the allyl amine. 
Basic conditions should be better suited in this respect, as formation 
of the iminium is usually acid-catalyzed. This would furthermore 
facilitate olefin functionalization via a faster syn oxypalladation on 
intermediate III. Indeed, we had shown in our previous work that 
basic conditions were necessary for the oxyalkynylation of olefins 
using a Pd0 catalyst.[10c,d] However, hemiaminal formation is usually 
performed under slightly acidic conditions. 
 
 
Scheme 3. Speculative analysis for the tether formation step. 
With these challenges in mind, we started our studies by 
examining the reaction of benzyl allyl amine (4a) with 
triisopropylsilylethynyl bromide (5a) in the presence of different 
bases and aldehydes 8 using the conditions optimized for the 
intramolecular oxyalkynylation reaction (Pd0 catalyst,[11] DPE-Phos 
(7a) as ligand, toluene, 60 °C) (Table 1).[10c] No product could be 
observed when using reported tether precursors such as 
acetaldehyde (8a) or formaldehyde (8b) (entries 1 and 2).[8,9] A 
small amount (about 5% yield) of desired product 9aa could be 
obtained only with benzaldehyde (8c) (entry 3). We speculated that 
this failure was due to the inefficient formation of the half aminal 
under the basic reaction conditions. To accelerate the formation of 
this key intermediate, more electron-deficient aldehydes were then 
examined (entries 4-6). With chloral (8d) and para-
trifluoromethylbenzaldehyde (8e), 9aa could indeed be obtained in 5 
and 25% yield respectively (entries 4 and 5). Finally, the best result 
was obtained with the commercial hemiacetal form 3 of 
trifluoroacetaldehyde,[12] and the oxyalkynylation product 9aa could 
be isolated in 92% yield after optimization of the reaction conditions 
(entry 6).[13] The best results were obtained using five equivalents of 
3. Nevertheless, 9aa could still be isolated in 71% yield when only 
1.1 equivalents of 3 were used (entry 7). The base played also a 
critical role in the success of the reaction, as both potassium 
carbonate (entry 8) or sodium tert-butoxide (entry 9) gave inferior 
results. Product 9aa was obtained with low diastereoselectivity (< 
2:1 dr) under all the reaction conditions tested, but this is 
inconsequential when considering that the trifluoromethyl 
stereocenter is not present in the final amino alcohol product.[14] 
Table 1. Optimization of the tethered oxyalkynylation.[a] 
 
entry tether ligand base Yield[b] 
1 8a (5.0 equiv) DPEPhos (7a) Cs2CO3 < 1% 
2 8b (5.0 equiv) DPEPhos (7a) Cs2CO3 < 1% 
3 8c (5.0 equiv) DPEPhos (7a) Cs2CO3 5% 
4 8d (5.0 equiv) DPEPhos (7a) Cs2CO3 5% 
5 8e (5.0 equiv) DPEPhos (7a) Cs2CO3 25% 
6 3 (5.0 equiv) DPEPhos (7a) Cs2CO3 92%[e] 
7 3 (1.0 equiv) DPEPhos (7a) Cs2CO3 71% 
8 3 (5.0 equiv) DPEPhos (7a) K2CO3 76% 
9 3 (5.0 equiv) DPEPhos (7a) NaOtBu 8% 
10 3 (5.0 equiv) XantPhos (7b) Cs2CO3 8% 
11 3 (1.5 equiv) XantPhos (7b) Cs2CO3 59% 
12 3 (5.0 equiv) BINAP (7c) Cs2CO3 6% 
13[c] 3 (5.0 equiv) PPh3 (7d) Cs2CO3 <5% 
14[c] 3 (1.5 equiv) (2-Furyl)3P (7e) Cs2CO3 93% 
15[c] 3 (1.5 equiv) (4-CF3C6H4)3P (7f) Cs2CO3 82% 
16[d] 3 (1.5 equiv) SPhos (7g) Cs2CO3 40% 
[a]Reactions were carried out on a 0.10 mmol scale. [b]Yields were calculated 
from 1H NMR spectra by using trimethoxybenzene as internal standard. [c]12 
mol% of ligand was used. [d]8 mol% of ligand was used. [e]Yield of isolated 
product on 0.30 mmol scale. 
 
The phosphine ligand had also a strong effect on the outcome of 
the reaction. Other biphosphine ligands gave 9aa in lower yields 
(entries 10-12). Interestingly, with XantPhos (7b) a better yield was 
obtained when only 1.5 equivalents of 3 were used (entry 11). 
Finally, the results obtained with monophosphine ligands were 
highly dependent of their structure. Whereas nearly no product 
formation was observed with triphenylphosphine (7d) (entry 13), 
good results were obtained with less electron-rich aryl phosphines 
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(entries 14 and 15). In particular tris(2-furyl)phosphine (7e) gave 
9aa in 93% yield (entry 14). The more sterically hindered electron-
rich SPhos ligand (7g) led to the formation of 9aa in only 40% yield 
(entry 16). From the screening of ligands, two optimum conditions 
emerged with either DPEPhos (7a) or tris(2-furyl)phosphine (7e) as 
ligands (entries 6 and 14). As more reproducible results were 
obtained on preparative scale using DPEPhos (7a) as ligand, it was 
used to examine the scope of the reaction (Scheme 4).[15]  
 
 
Scheme 4. Scope of allylamines in the tethered-oxyalkynylation reaction. [a] 
Reactions were carried out on a 0.30 mmol scale. Yield of isolated products. [b] 
The dr was was lower than 2:1 [c]The dr was enriched from 4:1 to 12:1 during 
column chromatography. 
We started by investigating the functional group tolerance of the 
oxyalkynylation by modifying the benzyl group on the allyl amine 
(Scheme 4, A). The reaction was successful in the presence of an 
ether, a trifluoromethyl, a bromo and a nitro groups, as well as an 
aldehyde (product 9ba-fa). It is particularly interesting to see that an 
aryl bromide group can be tolerated. This clearly indicated a higher 
reactivity of the alkynyl bromide towards oxidative addition. 
Oxazolines bearing an ortho-chlorobenzyl group or a furan 
heterocycle were obtained in 87% and 92% yield respectively 
(products 9ga and 9ha). Finally, the reaction was also successful for 
a simple methyl (product 9ia) or allyl (product 9ja) substituent. In 
contrast, only traces of product were observed when anilines or 
amides/carbamates were used as starting materials.[13] 
We then turned to the use of amines bearing a substituent at the 
allylic position (Scheme 4, B). This class of starting materials is 
especially interesting, as the existing stereocenter could be expected 
to control the formation of the C-O bond and more functionalized 
products are obtained. Unfortunately, only very low yields were 
observed when using diphosphines as ligands. In this case, tris(2-
furyl)phosphine (7e) was the ligand of choice, and oxazoline 9ka 
derived from methyl-substituted allyl amine 9k, was obtained in 
81% yield as a major diastereoisomer. With larger alkyl substituents, 
a nearly perfect diastereoselectivity was observed (products 9la and 
9ma). Aryl substituents could also be used: Phenyl-substituted 
oxazoline 9na was obtained in 90% and more than 12:1 dr, whereas 
heterocycle-substituted products 9oa and 9pa were formed in good 
yields but lower diastereoselectivity. 
Substitution of the olefin of the allyl amine was examined next 
(Scheme 4, C). 1,2-disubstituted olefins could not be used in the 
reaction. In contrast, the formation of tertiary ethers was possible 
when using XanthPhos (7b) as ligand. The reaction was successful 
in the case of a simple methyl group (product 9qa) and also for 
more functionalized alkyl chains (products 9ra and 9sa). 
Up to now, only triisopropylsilylethynylbromide (5a) had been 
used as partner for the multi-functionalization reaction. This was 
based on the excellent properties of this substrate in oxyalkynylation 
reactions[10c] and also its synthetic versatility as a precursor of 
terminal alkynes. Nevertheless, the use of functionalized alkynes 
would give a more convergent access into molecular complexity. 
Good yields could also be obtained with alkynes derived from 
tertiary or secondary propargylic alcohols (products 9ab and 9qc) 
and diynes (product 9qd) (Scheme 5, A).  
We finally extended the developed tether-strategy to 
oxyarylation (Scheme 5, B).[16] The reaction was successful 
 
Scheme 5. Scope of electrophiles in the tethered-oxyfunctionalization reaction. 
[a] Reactions were carried out on a 0.30 mmol scale. Yield of isolated products. 
The dr was lower than 3:1, unless otherwise noted. 
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provided aryl bromides slightly activated by an electron-
withdrawing group were used. Benzene bromides bearing a 
trifluoromethyl, a fluoro, a trifluoromethoxy or a chlorine group 
gave the oxyarylation products 9ae-h in 55-69% yield. Oxazoline 
9ai bearing a pyridine heterocycle could be obtained in 93% yield. 
Finally, oxyalkenylation was also successful and gave 
trifluormethyl-substituted alkene 9aj in 69% yield.  
The obtained building blocks are highly useful, as they contain 
three orthogonally protected functional groups (an alcohol, an amine 
and an alkyne). To demonstrate this synthetic potential, 9ba was 
synthesized on the gram scale (2.51 mmol, 1.15 g, 84%) and 
subjected to selective deprotection (Scheme 6). The hemiaminal 
tether could be readily removed, affording the aminoalcohol 10 in 
87% yield. Access to amine 11 was possible via DDQ-promoted 
PMB cleavage. Reductive opening of the hemiaminal yielded 
trifluoroethylamine 12 in excellent yield, while TIPS removal 
afforded the further functionalizable terminal alkyne 13. 
 
Scheme 6. Scale-up and orthogonal deprotections. Reaction conditions: a) 4.5 
equiv 3, 1.3 equiv 5a, 4 mol% 6, 6 mol% 7a, 1.3 equiv Cs2CO3 in toluene at 
60 °C; b) p-Toluenesulfonic acid, THF/MeOH, 60 °C; c) DDQ, CH2Cl2/H2O; d) 
DIBAL-H, toluene, -78 to -25 °C; e) TBAF, THF. 
In conclusion, we have developed the first Pd-catalyzed tethered 
carbo-etherification of allylamines for the synthesis of vicinal amino 
alcohols. The use of the hemiacetal of trifluoroacetaldehyde for in 
situ tether formation was key to enable high yield, regio- and 
diastereoselectivity under mild conditions. The reaction proceeded 
with broad scope and high functional group tolerance. The 
versatility of our method was highlighted by the possibility to 
introduce alkynyl, aryl and vinyl groups onto the alkene. Free 
alcohols, amines or terminal alkynes could be obtained orthogonally 
in one single step from the synthesized products. Future work will 
focus on the development of an asymmetric version of the 
transformation and the extension to other classes of tethers. 
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1. General Methods 
All reactions were carried out in oven dried glassware under an atmosphere of nitrogen, unless 
stated otherwise. For quantitative flash chromatography technical grade solvents were used. For 
flash chromatography for analysis, HPLC grade solvents from Sigma-Aldrich were used. THF, 
Et2O, CH3CN, toluene, hexane and CH2Cl2 were dried by passage over activated alumina under 
nitrogen atmosphere (H2O content < 10 ppm, Karl-Fischer titration).  In some cases solvents 
were degassed using freeze-thaw cycle. All chemicals were purchased from Acros, Aldrich, 
Fluka, VWR, Fluorochem, Aplichem or Merck and used without further purification, unless 
stated otherwise. Chromatographic purification was performed as flash chromatography using 
Macherey-Nagel silica 40-63, 60 Å, using the solvents indicated as eluent with 0.1-0.5 bar 
pressure. TLC was performed on Merck silica gel 60 F254 TLC aluminium plates and visualized 
with UV light and potassium permanganate stain. Melting points were measured on a calibrated 
Büchi B-540 melting point apparatus using open glass capillaries. 1H-NMR spectra were 
recorded on a Bruker DPX-400 400 MHz spectrometer in chloroform-d unless otherwise stated. 
All signals are reported in ppm with the internal chloroform signal at 7.26 ppm as standard unless 
otherwise stated. The data is being reported as (s = singlet, d = doublet, t = triplet, q = 
quadruplet, qi = quintet, m = multiplet or unresolved, br = broad signal, app = apparent, 
coupling constant(s) in Hz, integration, interpretation).13C-NMR spectra were recorded with 1H-
decoupling on a Bruker DPX-400 100 MHz spectrometer in chloroform-d unless otherwise 
stated. All signals are reported in ppm with the internal chloroform signal at 77.0 ppm as standard 
unless otherwise stated. Infrared spectra were recorded on a JASCO FT-IR B4100 
spectrophotometer with an ATR PRO410-S and a ZnSe prisma and are reported as cm-1 (w = 
weak, m = medium, s = strong, br = broad). Gas chromatographic and low resolution mass 
spectrometric measurements were performed on a Perkin-Elmer Clarus 600 gas chromatographer 
and mass spectrometer using a Perkin-Elmer Elite fused silica column (length: 30 m, diameter: 
0.32 mm) and Helium as carrier gas. High resolution mass spectrometric measurements were 
performed by the mass spectrometry service of ISIC at the EPFL on a MICROMASS (ESI) Q-
TOF Ultima API. Caesium carbonate was purchased from Aldrich and used without further 
purification. The bulk of this material is stored under nitrogen in a Vacuum Atmospheres 
Glovebox. Small portions (3-5 g) were removed from the glovebox in glass vials and weighed in 
the air. DPEPhos and XANTPhos were purchased from Acros and tri(2-furyl)phosphine was 
purchased from Aldrich. Allyamines 4a, 4b, 4d, 4f, 4g, 4h, 4i, 4j, 4q are commercially available 
from Fluorochem, Aldrich and Acros. Diastereomeric mixtures have been assigned by 2D NMR 
experiments including COSY/ROESY/HSQC/HMBC. 
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2. Optimization. 
General method for the optimization: 
A sealed oven-dry microwave vial under nitrogen was charged with dry degassed toluene (0.3 
mL), the tether , the allylamine (0.100 mmol, 1.0 eq) and (bromoethynyl)triisopropylsilane (34 
mg, 0.13 mmol, 1.3 eq). The resulting solution was stirred 10-60 min at 50 °C and subsequently 
transferred via canula to a sealed oven-dry 2 mL microwave vial under nitrogen containing the 
palladium source, the ligand and the base (0.130 mmol, 1.3 eq) and dry degassed toluene (0.20 
mL) that have been previously premixed at 50 °C for 3 min. The resulting mixture was stirred at 
60 °C for 15 h. The reaction mixture was cooled to 23 °C, concentrated under reduced pressure 
and analyzed by NMR spectroscopy.  
 
 
Entry[a] Tether Pd source  Ligand Base Yield[b]  
1 8a (5.0 equiv) 6 (4 mol%) DPEPhos (7a) Cs2CO3 < 1% 
2 8b (5.0 equiv) 6 (4 mol%) DPEPhos (7a) Cs2CO3 < 1% 
3 8c (5.0 equiv) 6 (4 mol%) DPEPhos (7a) Cs2CO3 5% 
4 8d (5.0 equiv) 6 (4 mol%) DPEPhos (7a) Cs2CO3 5% 
5 8e (5.0 equiv) 6 (4 mol%) DPEPhos (7a) Cs2CO3 25% 
6 3 (5.0 equiv) 6 (4 mol%) DPEPhos (7a) Cs2CO3 92%
[c] 
7 3 (1.0 equiv) 6 (4 mol%) DPEPhos (7a) Cs2CO3 71% 
8 3 (5.0 equiv) 6 (4 mol%) DPEPhos (7a) K2CO3 76% 
9 3 (5.0 equiv) 6 (4 mol%) DPEPhos (7a) NaOtBu 8% 
10 3 (1.2 equiv) Pd(dba)2 (8 mol%) DPEPhos (7a) (16 mol %) CsOH <5% 
11 3 (1.2 equiv) Pd(dba)2 (8 mol%) DPEPhos (7a) (16 mol %) K3PO4 <5% 
12 3 (1.2 equiv) Pd(dba)2 (8 mol%) DPEPhos (7a) (16 mol %) EtN(
iPr)2 <5% 
13 3 (5.0 equiv) 6 (4 mol%) XantPhos (7b) Cs2CO3 8% 
14 3 (1.5 equiv) 6 (4 mol%) XantPhos (7b) Cs2CO3 59% 
15 3 (5.0 equiv) 6 (4 mol%) BINAP (7c) Cs2CO3 6% 
16 3 (5.0 equiv) 6 (4 mol%) PPh3 (7d) (12 mol %) Cs2CO3 <5% 
17 3 (1.5 equiv) 6 (4 mol%) (2-Furyl)3P 7e (12 mol %) Cs2CO3 93% 
18 3 (1.5 equiv) 6 (4 mol%) (4-CF3C6H4)3P 7f (12 mol %) Cs2CO3 82% 
19 3 (1.5 equiv) 6 (4 mol%) SPhos (7g) (8 mol %) Cs2CO3 40% 
20 3 (1.5 equiv) 6 (4 mol%) (2-Furyl)3P 7e (12 mol %) Cs2CO3 93% 
21 3 (1.5 equiv) 6 (4 mol%) (4-CF3C6H4)3P 7f (12 mol %) Cs2CO3 82% 
22 3 (1.5 equiv) 6 (4 mol%) JohnPhos (8 mol %) Cs2CO3 <5% 
23 3 (1.5 equiv) 6 (4 mol%) XPhos (8 mol %) Cs2CO3 <5% 
24 3 (1.5 equiv) 6 (4 mol%) PCy3 (12 mol %) Cs2CO3 <5% 
25 3 (1.5 equiv) 6 (4 mol%) PnBu3 (12 mol %) Cs2CO3 <5% 
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26 3 (1.5 equiv) 6 (4 mol%) P(OiPr)3 (12 mol %) Cs2CO3 <5% 
27 3 (5.0 equiv) none DPEPhos (7a) Cs2CO3 < 1% 
28 3 (1.2 equiv) Pd(dba)2 (8 mol%) DPEPhos (7a) (16 mol %) Cs2CO3 55% 
29 3 (1.2 equiv) 
[Pd(allyl)(COD)]BF4 
(8mol%) 
DPEPhos (7a) (12 mol %) Cs2CO3 47% 
30 3 (1.2 equiv) Pd2dba3 (8 mol %) DPEPhos (7a) (24 mol %) Cs2CO3 69% 
31 3 (1.2 equiv) Pd2dba3 (4 mol %) DPEPhos (7a) (12 mol %) Cs2CO3 44% 
32 3 (5.0 equiv) 6 (2 mol%) DPEPhos (7a) (3 mol %) Cs2CO3 84% 
33[d] 3 (5.0 equiv) 6 (4 mol%) DPEPhos (7a)  Cs2CO3 87% 
34 3 (5.0 equiv) 6 (4 mol%) DPEPhos (7a) (4 mol%) Cs2CO3 87% 
35 3 (5.0 equiv) 6 (4 mol%) DPEPhos (7a) (8 mol%) Cs2CO3 83% 
36[e] 3 (1.2 equiv) Pd(dba)2 (8 mol%) DPEPhos (7a) (16 mol%) Cs2CO3 < 5% 
37[f] 3 (1.2 equiv) Pd(dba)2 (8 mol%) DPEPhos (7a) (16 mol%) Cs2CO3 13% 
[a] Reactions were carried out on a 0.10 mmol scale in a sealed tube. [b] Yields were calculated from 1H NMR spectra by using 
trimethoxybenzene as internal standard. [c] Yield of isolated product on 0.30 mmol scale. [d] Reaction performed at 75 °C. [e] tert-butyl 
allylcarbamate was used instead of 4a. [f] N-allyl-4-methoxyaniline was used instead of 4a. 
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3. Synthesis of starting materials. 
N-(4-(Trifluoromethyl)benzyl)prop-2-en-1-amine (4c) 
 
4-(Trifluoromethyl)benzaldehyde (15) (1.37 mL, 10.0 mmol, 1.0 eq) and prop-2-en-1-amine (16) 
(0.571 g, 10.0 mmol, 1.0 eq) were mixed in 1,2-dichloroethane (35 mL) and then treated with 
sodium triacetoxyborohydride (3.0 g, 14 mmol, , 1.4 eq). The mixture was stirred at rt under a N2 
atmosphere for 2.5 h. The reaction mixture was quenched by adding aqueous saturated NaHCO3 
(15 mL), and the product was extracted with EtOAc (3x30 mL). The EtOAc extract was dried 
(MgSO4), and the solvent was evaporated under reduced pressure. The crude product was purified 
by column chromatography (SiO2, 10:1:0.1 Pentane:EtOAc:Et3N) to afford the title compound 4c 
as a pale yellow oil (1.83 g, 8.50 mmol, 85% yield). 
 
Rf 0.20 (Pentane:EtOAc 4:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.58 (d, J = 8.0 Hz, 2H, ArH), 7.45 (d, J = 8.0 Hz, 2H, 
ArH), 5.92 (ddt, J = 17.2, 10.3, 6.0 Hz, 1H, CHCH2), 5.21 (m, 1H, CHCH2), 5.14 (m, 1H, 
CHCH2), 3.86 (s, 2H, ArCH2), 3.28 (m, 2H, NCH2), 1.65 (bs, 1H, NH). 
13C NMR (101 MHz, Chloroform-d) δ 144.4, 136.5, 129.4 (q, J = 32.2 Hz), 128.5, 125.5 (m), 
124.5 (q, J = 272.2 Hz), 116.5, 52.7, 51.8. 
IR νmax 3394 (w), 2831 (w), 2830 (w), 1646 (w), 1620 (w), 1458 (w), 1420 (w), 1329 (s), 1167 
(m), 1127 (s), 1069 (w), 1021 (w), 925 (w), 844 (w), 823 (w), 796 (w), 784 (w), 763 (w), 728 
(w). 
HRMS (ESI) calcd. for C11H13F3N
+ [M+H]+ 216.0995; found 216.0994. 
 
N-(4-Nitrobenzyl)prop-2-en-1-amine (4e) 
 
4-Nitrobenzaldehyde (17) (1.21 g, 8.00 mmol) and allylamine (16) (0.46 g, 8.0 mmol) were 
dissolved in 25 mL dichloroethane. Sodium triacetoborohydride (5.1 g, 24 mmol, 3.0 eq) was 
then added to the solution and the resulting mixture was stirred at RT for 1.5h. The reaction was 
then quenched with saturated NaHCO3 (15 mL), the product was extracted with EtOAc (3x25 
mL), then poured into 1 M aq. HCl (50 mL). The aqueous layer was washed with EtOAc (3x25 
mL), and basified (pH 14) with KOH. The resulting aqueous layer was extracted with CH2Cl2 
(3x25 mL). The combined organic layers were washed with saturated aqueous NaCl and dried 
(MgSO4). The solvent was evaporated to give the crude product that was purified by column 
chromatography (SiO2 2:1:0.1 Pentane:EtOAc:Et3N) to afford the title compound 4e as an orange 
oil (1.32 g, 8.50 mmol, 86% yield, 95 % purity). 
 
Rf 0.10 (Pentane:EtOAc 4:1).  
1H NMR (400 MHz, Chloroform-d) δ 8.19 (d, J = 8.6 Hz, 2H, ArH), 7.51 (d, J = 8.6 Hz, 2H, 
ArH), 5.91 (ddt, J = 16.4, 10.3, 5.9 Hz, 1H, CH=CH2), 5.27 – 5.08 (m, 2H, CH=CH2), 3.90 (s, 
2H, ArCH2), 3.28 (m, 2H, NCH2), 1.51 (bs, 1H, NH). 
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13C NMR (101 MHz, Chloroform-d) δ 148.0, 147.2, 136.2, 128.8, 123.7, 116.8, 52.3, 51.8. 
IR νmax 3668 (w), 3080 (w), 2975 (s), 2906 (s), 1729 (w), 1674 (w), 1651 (w), 1603 (w), 1522 
(s), 1454 (w), 1409 (m), 1402 (m), 1388 (m), 1348 (s), 1253 (w), 1204 (w), 1177 (w), 1136 (w), 
1071 (s), 1062 (s), 915 (w), 860 (w), 803 (w), 739 (w). 
Spectra data was consistent with the values reported in literature.1  
 
4-((Allylamino)methyl)benzaldehyde (4f) 
 
To a solution of 4-((allylamino)methyl)benzonitrile (18) (0.861 g, 5.00 mmol, 1.0 eq) in 
anhydrous toluene (12.5 mL) was added DIBAL-H (1 M in hexane, 6.50 mL, 6.50 mmol, 1.3 eq), 
keeping the internal temperature between -10 and -5 °C. After stirring at 0 °C for 2 h, ice cold 
HCl (10% aq. sol., 50 mL) was added carefully. The layers were separated and the aqueous phase 
washed with CH2Cl2 (3x15 mL). The resulting aqueous layer was basified (pH 14) with KOH and 
extracted with CH2Cl2 (3x50 mL). The combined organic layers were washed with saturated 
aqueous NaCl and dried (MgSO4). The solvent was evaporated to give the crude product that was 
purified by passing through a short pad of silica, eluting with EtOAc to afford the pure title 
compound 4fa as a pale yellow oil (0.797 g, 4.55 mmol, 91% yield). 
N. B.: this compound readily polymerized, preventing us from obtaining a clean 13C NMR 
spectrum . 
 
1H NMR (400 MHz, Chloroform-d) δ 10.00 (s, 1H, CHO), 7.89 – 7.78 (m, 2H, ArH), 7.57 – 7.45 
(m, 2H, ArH), 5.93 (ddt, J = 17.1, 10.2, 6.0 Hz, 1H, CHCH2), 5.25 – 5.17 (m, 1H, CHCH2), 5.16 
– 5.10 (m, 1H, CHCH2), 3.89 (s, 2H, ArCH2), 3.29 (m, 2H, NCH2), 1.52 (bs, 1H, NH). 
IR νmax 3664 (w), 3074 (w), 2995 (w), 2916 (w), 2827 (m), 2735 (w), 1698 (s), 1643 (w), 1607 
(m), 1578 (w), 1449 (w), 1420 (w), 1389 (w), 1363 (w), 1341 (w), 1304 (w), 1254 (w), 1210 (m), 
1166 (m), 1108 (w), 1072 (w), 997 (m), 922 (m), 848 (m), 823 (m), 783 (m). 
HRMS (ESI) calcd. for C11H14NO
+ [M+H]+ 176.1070; found 176.1068. 
 
N-Benzylbut-3-en-2-amine (4k) 
 
Following a reported procedure, 2 
1) MeSO2Cl (2.86 g, 25.0 mmol, 1.25 eq) was added dropwise at 0 °C to a CH2Cl2 (60 mL) 
solution of but-3-en-2-ol (19) (1.44 g, 20.0 mmol, 1.0 eq) and Et3N (3.04 g, 30.0 mmol, 1.5 eq). 
The mixture was stirred at the same temperature for 2 h, resulting in a large amount of white 
precipitate. Saturated Na2CO3 (30 mL) was then added to quench the reaction. After the 
separation of the organic layer, extraction of the aqueous layer with CH2Cl2 (20 mL x 2) and 
washing with brine, the combined organic layer was dried with MgSO4. The solvent was 
                                                 
1 Benedetti, E.; Lomazzi, M.; Tibiletti, F.; Goddard, J.-P.; Fensterbank, L.; Malacria, M.; Palmisano, G.; Penoni, A. 
Synthesis, 2012, 44, 3523. 
2 Zhao, S.-B.; Bilodeau, E.; Lemieux, V.; Beauchemin , A. M. Org. Lett. 2012, 14, 5082. 
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removed under reduced pressure, and the residue was dried under vacuum to afford but-3- en-2-yl 
methanesulfonate (3.15 g, 21.0 mmol, <= 100%), which was used directly in next step.  
2) But-3-en-2-yl methanesulfonate (2.13 g, 14.0 mmol, 1.0 eq) was added dropwise to a rapidly 
stirring neat benzyl amine solution (4.50 g, 42.0 mmol, 3.0 eq) at room temperature. After stirring 
overnight, NaOH (10%, 10 mL) was added. After extraction with CH2Cl2 (20 mL), separation of 
organic layer, drying with Na2SO4, and removal of the solvent under reduced pressure, the 
residue was purified by column chromatography (EtOAc:Hexanes 3:1) to afford the title 
compound 4k as a colorless oil (2.48 g, 15.4 mmol, 77% yield for 2 steps).  
 
1H NMR (400 MHz, Chloroform-d) δ 7.30-7.22 (m, 5H, ArH), 5.72 (ddd, J = 17.6, 10.1, 7.6 Hz 
1H, CHCH2), 5.14 (m, 1H, CHCH2), 5.09 (m, 1H, CHCH2), 3.80 (d, J = 13.1 Hz 1H, PhCH2), 
3.67 (d, J = 13.1 Hz 1H, PhCH2), 3.20 (m, 1H, NCH), 1.26 (br, NH, 1H, NH) 1.16 (d, J = 6.5 Hz, 
3H, Me). 
13C NMR (100 MHz, Chloroform-d) δ 142.7, 140.8, 128.5, 128.3, 126.9, 114.8, 56.2, 51.5, 21.9. 
Spectra data was consistent with the values reported in literature.3 
 
 
2-Methyl-N-(3-methylbutylidene)propane-2- sulfinamide (22) 
 
 To a solution of 3-methylbutanal (20) (1.24 g, 14.4 mmol, 1.2 eq) in CH2Cl2 (74 mL) were added 
successively 2-methylpropane-2-sulfinamide (21) (1.45 g, 12.0 mmol, 1.0 eq), MgSO4 (7.22 g, 
60.0 mmol, 5.0 eq) and PPTS (0.302 g, 1.20 mmol, 0.10 eq). The resulting white suspension was 
stirred at rt for 20 h, then filtered through a pad of Celite and concentrated in vacuo. Column 
chromatography of the residue on (SiO2, Pentane:EtOAc 8:2) afforded the title compound 22 as a 
colourless oil (1.99 g, 10.6 mmol, 88 % yield). 
 
1H NMR (400 MHz, Chloroform-d) δ 8.06 (t, 1 H, J = 5.2 Hz, NH), 2.45-2.37 (m, 2 H, CH2), 
2.12-1.99 (m, 1 H, CH), 1.20 (s, 9 H, tBu), 0.99 (d, 6 H, J = 6.6 Hz, CH(CH3)2). 
Spectra data was consistent with the values reported in literature.4 
 
 
 
N-Benzyl-5-methylhex-1-en-3-amine (4l) 
                                                 
3 Dubovyk, I.; Watson, I. D. G.; Yudin, A. K. J. Am. Chem. Soc. 2007, 129, 14172. 
4 Frantz, M.-C.; Pierce, J. G.; Pierce, J. M.; Kangying, L.; Qingwai, W.; Johnson, M.; Wipf, P. Org. Lett. 2011, 13, 
2318. 
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1) Following a slightly modified procedure,5 a solution of vinyl magnesium bromide in THF (1.0 
M, 15.9 mL, 15.9 mmol, 3.0 eq) was added via cannula to a cooled (-48 °C) solution of 2-methyl-
N-(3-methylbutylidene)propane-2-sulfinamide (22) (1.00 g, 5.28 mmol, 1.0 eq) in CH2Cl2 (26.4 
mL). The reaction mixture was stirred at -48 °C for 8 h and then allowed to slowly warm to rt 
overnight (12 h). The reaction was quenched with a 1:2:1 brine/water/NH4Cl solution (30 mL) 
while stirring in water bath. Stirring was continued for 30 min until all solid particles were 
dissolved. Upon separation of the layers, the aqueous layer was extracted once with CH2Cl2, and 
the combined CH2Cl2 layers were dried. After filtration through a Celite pad followed by 
concentration under reduced pressure, the resultant 2-methyl-N-(5-methylhex-1-en-3-yl)propane-
2-sulfinamide was collected as a yellow oil (1.02 g, <4.69 mmol, <89% yield). The crude product 
was directly used for the next step.  
 
2) Following a slightly modified procedure,5 (2-methyl-N-(5-methylhex-1-en-3-yl)propane-2-
sulfinamide (1.02 g, 4.69 mmol) was cleaved by addition of a 2 N HCl solution in Et2O (4.69 mL, 
9.38 mmol, 2.0 eq) and methanol (5 mL). After 30 min, the reagents/solvents were removed by 
passing N2 over the solution. The resultant amine salts were re-dissolved in CH2Cl2 (30 mL) and 
washed with 1 M KOH (3x15 mL) in order to obtain the free amine. Upon drying, filtration, and 
solvent removal under reduced pressure, the crude free amine was obtained as a yellow solution 
in CH2Cl2 that was directly used in the next step without further purification. 
 
3) 5-Methylhex-1-en-3-amine (398 mg, 3.52 mmol, 1.0 eq) and benzaldehyde (0.356 mL, 3.52 
mmol, 1.0 eq) were mixed in methanol (11 mL) at rt under a N2 atmosphere. The mixture was 
stirred at rt until the aldimine formation was completed (TLC). The reaction mixture was 
carefully treated with solid sodium borohydride (266 mg, 7.03 mmol, 2 eq). The reaction mixture 
was stirred for 2 hour and quenched with 1 M KOH (10 mL). The product was extracted with 
CH2Cl2 (3x20 mL). The combined organic phases were concentrated under reduced pressure and 
dissolved in 15 mL Et2O. The organic phase was extracted with HCl 1M (3x20 mL). The 
resulting aqueous phase was basified with KOH (pH 14) and extracted with CH2Cl2 (3x20 mL). 
The combined organic extract was washed with saturated aqueous NaCl and dried (MgSO4). The 
solvent was evaporated under reduced pressure to give the crude product that was purified by 
passing through a short pad of silica, eluting with CH2Cl2 and then EtOAc:Et3N (100:1) to afford 
the pure title compound 4l as a colourless oil (679 mg, 3.34 mmol, 63% yield over 3 steps). 
 
1H NMR (400 MHz, Chloroform-d) 7.34 – 7.29 (m, 4H, ArH), 7.27 – 7.20 (m, 1H, ArH), 5.60 
(ddd, J = 17.0, 10.3, 8.3 Hz, 1H, CH=CH2), 5.16 – 5.08 (m, 2H, CH=CH2), 3.83 (d, J = 13.1 Hz, 
1H, PhCH2), 3.63 (d, J = 13.1 Hz, 1H, PhCH2), 3.12 – 3.05 (m, 1H, NCH), 1.66 (m, 1H, 
(CH3)2CH), 1.56 – 1.42 (bs, 1H, NH), 1.42 – 1.25 (m, 2H, (CH3)2CHCH2), 0.87 (d, J = 3.4 Hz, 
3H, (CH3)2CH), 0.85 (d, J = 3.4 Hz, 3H, (CH3)2CH). 
13C NMR (101 MHz, Chloroform-d) δ 141.6, 140.8, 128.5, 128.3, 126.9, 116.0, 59.5, 51.4, 45.2, 
24.8, 23.2, 22.6. 
1H NMR Spectra data was consistent with the values reported in literature.6 
                                                 
5 Lee, A.; Ellman, J. A. Org. Lett. 2001, 3, 3707. 
6 Brettle, R.; Jafri, I. A. J. Chem. Soc., Perkin Trans. 1 1983, 387. 
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N-(2-(benzyloxy)ethylidene)-2-methylpropane-2-sulfinamide (24) 
 
To a 0.5 M solution of 2-methylpropane-2-sulfinamide (21) (533 mg, 4.40 mmol, 1.1 eq) in 
CH2Cl2 (8 mL) was added CuSO4 (1.60 g, 10.0 mmol, 2.5 eq) and the 2-(benzyloxy)acetaldehyde 
(23) (601 mg, 4.00 mmol, 1.0 eq). The reaction mixture was stirred for 72 h at rt. The reaction 
mixture was filtered through a pad of Celite, and the filter cake was washed with CH2Cl2 and the 
filtrate concentrated under reduced pressure. Purification by column chromatography (SiO2, 
Pentane:EtOAc 4:1 to 1:1) afforded the title compound 24 as a clear colourless oil (973 mg, 3.84 
mmol, 96% yield). 
 
1H NMR (400 MHz, CDCl3) δ 8.14-8.12 (t, 1H, J = 3.2 Hz, NCH), 7.38-7.31 (m, 5H, ArH), 4.64 
(s, 2H, PhCH2), 4.45-4.41 (m, 1H, OCH2), 4.41-4.36 (m, 1H, OCH2), 1.22 (s, 9H, tBu). 
Spectra data was consistent with the values reported in literature.7 
 
N-(1-(Benzyloxy)but-3-en-2-yl)-2-methylpropane-2-sulfinamide (25) 
 
Following a reported procedure,8 a solution of trimethylaluminum (2.0 M, 1.30 mL, 2.60 mmol, 
1.1 eq) in toluene was slowly added to a solution of N-(2-(benzyloxy)ethylidene)-2-
methylpropane-2-sulfinamide (24) (600 mg, 2.37 mmol, 1.0 eq) in toluene (11.2 mL) at -78 °C. 
The solution was stirred for 30 min at this temperature and a solution of vinylmagnesium 
bromide (1.0 M, 3.43 mL, 3.43 mmol, 1.45 eq) in THF was slowly added keeping the internal 
temperature below -70 °C. The reaction mixture was stirred at -78 °C until complete conversion 
of the imine was observed by TLC. The reaction was then quenched with a saturated solution of 
Na2SO4 and let warm up to rt. The phases were then separated. The organic phase was dried over 
MgSO4, filtered and concentrated under reduced pressure. The crude product was purified by 
column chromatography (Pentane:EtOAc 4:1) to afford the title compound 25 a pale yellow oil 
(548 mg, 1.95 mmol, 82% yield). 
1H NMR (400 MHz, Chloroform-d) δ 7.39 – 7.27 (m, 5H, ArH), 5.66 (ddd, J = 17.2, 10.3, 7.0 
Hz, 1H, CH=CH2), 5.35 (m, 1H, CH=CH2), 5.24 (m, 1H, CH=CH2), 4.61 (d, J = 12.0 Hz, 1H, O 
CH2Ph), 4.49 (d, J = 12.0 Hz, 1H, OCH2Ph), 4.11 (m, 1H, NCH), 3.86 (bs, 1H, NH), 3.58 (dd, J 
= 9.6, 4.2 Hz, 1H, BnOCH2), 3.48 (dd, J = 9.6, 7.9 Hz, 1H, BnOCH2), 1.22 (s, 9H, tBu). 
Spectra data was consistent with the values reported in literature.8 
 
 
                                                 
7 Tang, T. P.; Volkman, S. K.; Ellman, J. A. J. Org. Chem. 2001, 66, 8772. 
8 Van den Nieuwendijk, A. M. C. H.; Ruben, M.; Engelsma, S. E.; Risseeuw, M. D. P.; van den Berg, R. J. B. H. N.; 
Boot, R. G.; Aerts, J. M.; Brussee, J.; van der Marel, G. A.; Overkleeft, H. S. Org. Lett., 2010, 12, 3957. 
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N-Benzyl-1-(benzyloxy)but-3-en-2-amine (4m) 
 
Multistep procedure: 
1) Following a slightly modified procedure,5 N-1-(benzyloxy)but-3-en-2-yl)-2-methylpropane-2-
sulfinamide (26) (550 mg, 1.95 mmol, 1.0 eq) was cleaved by addition of a HCl solution (2 N in 
Et2O, 1.95 mL, 3.90 mmol, 2.0 eq) and methanol (4 mL). After 30 min, the reagents/solvents 
were removed by passing N2 over the solution. The resultant amine salts were re-dissolved in 
CH2Cl2 (20 mL) and washed with 1 M KOH (15 mL) in order to obtain the free amine. Upon 
drying (MgSO4), filtration, and solvent removal under reduced pressure, the crude free amine was 
obtained as a yellow solution in CH2Cl2 that was directly used in the next step without further 
purification. 
 
2) 1-(Benzyloxy)but-3-en-2-amine (340 mg, 1.92 mmol, 1.0 eq) and benzaldehyde (0.194 mL, 
1.92 mmol, 1.0 eq) were mixed in methanol (5 mL) with 4Å MS at rt under a N2 atmosphere. The 
mixture was stirred at rt until the aldimine formation was completed (TLC monitoring). The 
aldimine in MeOH was carefully treated with solid NaBH4 (116 mg, 3.07 mmol, 1.6 eq). The 
reaction mixture was stirred for 1 hour and quenched with 1 M KOH (5 mL). The product was 
extracted with CH2Cl2 (3x20 mL). The combined organic phases were dried over MgSO4 and 
concentrated under reduced pressure. The crude product was purified by passing through a short 
pad of silica, eluting with Pentane:EtOAc:Et3N 9:1:0.1 to afford the pure title compound 4m as a 
colourless oil (430 mg, 1.61 mmol, 83% yield over 2 steps). 
 
Rf 0.55 (Pentane:EtOAc 3:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.38 – 7.21 (m, 10H, ArH), 5.70 (ddd, J = 17.5, 10.2, 7.5 
Hz, 1H, CH=CH2), 5.31 – 5.18 (m, 2H, CH=CH2), 4.54 – 4.46 (m, 2H, OCH2Ph), 3.86 (d, J = 
13.3 Hz, 1H, PhCH2N), 3.65 (d, J = 13.4 Hz, 1H, PhCH2N), 3.53 – 3.36 (overlapping signals, 3 
m, 3H, BnOCH2 and NCH), 1.99 (bs, 1H, NH). 
13C NMR (101 MHz, Chloroform-d) δ 140.7, 138.3, 137.9, 128.6, 128.5, 128.3, 127.8, 127.7, 
126.9, 117.9, 73.6, 73.3, 60.7, 51.3. 
IR νmax 3371 (w), 3033 (w), 2857 (w), 1701 (w), 1609 (w), 1496 (w), 1459 (w), 1362 (w), 1209 
(w), 1164 (w), 1098 (s), 1028 (w), 1000 (w), 928 (w), 844 (w), 810 (w), 798 (w), 784 (w), 740 
(s). 
HRMS (ESI) calcd for C18H22NO
+ [M+H]+ 268.1696; found 268.1702. 
 
N-benzyl-1-phenylmethanimine (29) 
 
Following a reported procedure,9 a 250 mL flask was charged with 3Å MS (30 g), flame-dried 
and cooled under a positive pressure of nitrogen. CH2Cl2 (50 mL) and benzaldehyde (27) (4.05 
mL, 40.0 mmol, 1.02 eq) were added. Benzylamine (28) (4.29 mL, 39.2 mmol, 1.00 eq) was then 
added dropwise and the reaction was followed by TLC. After completion of the reaction, the 
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molecular sieves were removed by filtration, and the product was concentrated under reduced 
pressure. Vacuum distillation was directly made to purify the product (118 °C under reduced 
pressure) to give a colorless liquid. The residue was purified by vacuum distillation under 
reduced pressure (118 °C, 0.05 mmHg) to afford the title compound 29 as a colorless oil (4.62 g, 
24.4 mmol, 62% yield). 
 
1H NMR (400 MHz, Chloroform-d) δ  8.40 (s, 1H, NCH), 7.80-7.78 (m, 2H, ArH), 7.44-7.41 (m, 
3H, ArH), 7.37-7.33 (m, 4H, ArH), 7.29-7.25 (m, 1H, ArH), 4.84 (d, 2 H, PhCH2). 
Spectra data was consistent with the values reported in literature.9  
 
N-benzyl-1-phenylprop-2-en-1-amine (4n) 
 
Following a slightly modified procedure,10 N-benzylidene-1-phenylmethanamine (29) (1.17 g, 
6.00 mmol, 1.0 eq) was dissolved in toluene (15 mL), cooled to -78 ºC, and BF3·Et2O (48 %Wt, 
7.92 mL, 30.0 mmol, 5.0 eq) was added under N2. After 10 min at -78 ºC, a solution of vinyl 
magnesium bromide in THF (0.7 M, 34.3 mL, 24.0 mmol, 4.0 eq) was added dropwise. The 
resulting mixture was allowed to slowly warm up to rt and stirred for further 2 h. Then, the 
reaction mixture was poured into 2 N aqueous NaOH (30 mL), and extracted with Et2O (3x30 
mL). The organic layer was dried over MgSO4 and concentrated under reduced pressure. The 
residue was purified by column chromatography (SiO2, Pentane:EtOAc:Et3N 10:1:0.1) to afford 
the title compound 4n as a colorless oil (0.992 g, 4.44 mmol, 74% yield). 
 
1H NMR (400 MHz, Chloroform-d) δ 7.40 – 7.30 (m, 8H, ArH), 7.26 (m, 2H, ArH), 5.95 (ddd, J 
= 17.2, 10.2, 7.1 Hz, 1H, CH=CH2), 5.28 – 5.18 (m, 1H, CH=CH2), 5.16 – 5.10 (m, 1H, 
CH=CH2), 4.23 (d, J = 7.2 Hz, 1H, PhCH), 3.78 – 3.69 (m, 2H, PhCH2), 1.61 (bs, 1H, NH). 
13C NMR (101 MHz, Chloroform-d) δ 142.9, 141.1, 140.5, 128.7, 128.5, 128.3, 127.5, 127.3, 
127.0, 115.3, 65.2, 51.4. 
Spectra data was consistent with the values reported in literature.11 
 
N-benzyl-1-(furan-2-yl)methanimine (31) 
 
Following a reported procedure,9 a 250 mL flask was charged with 3Å MS (30 g), flame-dried 
and cooled under a positive pressure of nitrogen. CH2Cl2 (50 mL) and 2-furaldehyde (30) (3.30 
mL, 40.0 mmol, 1.02 eq) were added. Benzylamine (28) (4.29 mL, 39.2 mmol, 1.00 eq) was then 
added dropwise and the reaction was followed by TLC. After completion of the reaction, the 
molecular sieves were removed by filtration, and the product was concentrated under reduced 
                                                 
9 Joly, G. D.; Jacobsen, E. N. J. Am. Chem. Soc. 2004, 126, 4102. 
10 Solé, D.; Serrano, O. J. Org. Chem. 2010, 75, 6267. 
11 Takeuchi, R.; Ue, N.; Tanabe, K.; Yamashita, K.; Shiga, N. J. Am. Chem. Soc. 2001, 123, 9525. 
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pressure. Vacuum distillation was directly made to purify the product (118 °C under reduced 
pressure) to give a colorless liquid. The residue was purified by vacuum distillation under 
reduced pressure (127 °C, 0.05 mmHg) to afford the title compound 31 as a colorless oil (5.89 g, 
31.8 mmol, 81% yield). 
 
1H NMR (400 MHz, Chloroform-d) δ   8.16 (s, 1H, NCH), 7.52-7.47 (m, 1H, HetArH), 7.35-7.29 
(m, 4H, ArH), 7.27-7.23 (m, 1H, ArH), 6.77 (d, J = 3.3 Hz, 1H, HetArH), 6.47 (dd, J = 1.8, 3.4 
Hz, 1H, HetArH), 4.78 (s, 2 H, PhCH2). 
Spectra data was consistent with the values reported in literature.9 
 
N-benzyl-1-(furan-2-yl)prop-2-en-1-amine (4o) 
 
Following a slightly modified procedure,12 a solution of distilled N-(furan-2-ylmethylene)-1-
phenylmethanamine (31) (1.11 g, 6.00 mmol, 1.0 eq) in anhydrous THF (20 mL) was prepared 
under nitrogen. After cooling to -78 °C, a diethyl zinc solution in hexanes (1 M, 9.00 mL, 9.00 
mmol, 1.5 eq) and, 10 min later, a solution vinylmagnesium bromide in THF (0.7 M, 12.9 mL, 
9.00 mmol, 1.5 eq) were added. The stirred solution was kept for 1 h at -78 °C, afterwards the 
cooling bath was removed. When the reaction mixture reached room temperature, dilution with 
5% w/v aq. NaOH (10 mL) and extraction with ethyl ether (3x15 mL) followed. The organic 
phases were collected, dried (MgSO4) and concentrated under vacuum. The crude amine was 
purified by column chromatography (SiO2, Pentane:EtOAc:Et3N 10/1/0.1 to 4:1:0.1) to afford the 
title compound 4o as a colourless oil (1.05 g, 4.92 mmol, 82 % yield). 
 
1H NMR (400 MHz, Chloroform-d) δ 7.38 (m, 1H, HetArH), 7.35 – 7.29 (m, 4H, ArH), 7.29 – 
7.22 (m, 1H, ArH), 6.33 (dd, J = 3.1, 1.8 Hz, 1H, HetArH), 6.21 (d, J = 3.1 Hz, 1H, HetArH), 
5.98 (ddd, J = 17.2, 10.2, 7.1 Hz, 1H, CH=CH2), 5.31 – 5.20 (m, 2H, CH=CH2), 4.32 (d, J = 7.1 
Hz, 1H, NCH), 3.77 (s, 2H, PhCH2), 1.82 (bs, 1H, NH). 
13C NMR (101 MHz, Chloroform-d) δ 155.4, 142.0, 140.1, 137.6, 128.6, 128.4, 127.1, 117.1, 
110.2, 106.6, 58.4, 51.1. 
Spectra data was consistent with the values reported in literature.13 
 
 
1-(Benzo[b]thiophen-2-yl)-N-benzylprop-2-en-1-amine (4p) 
 
Multistep procedure: 
                                                 
12 Ghelfi, F.; Parsons, A. F.; Tommasini, D.; Mucci, A. Eur. J. Org. Chem. 2001, 1845. 
13 Leitner, A.; Shu, C.; Hartwig, J. F. Org. Lett. 2005, 7, 1093. 
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1) Following a slightly modified procedure,10 a 25 mL flask was charged with 3Å MS (4 g), 
flame-dried and cooled under a positive pressure of nitrogen. CH2Cl2 (17 mL) and 
benzothiophene-2-carbaldehyde (32) (0.827 g, 5.10 mmol, 1.02 eq) were added. Benzylamine 
(0.546 mL, 5.00 mmol, 1.00 eq) was then added dropwise and the reaction was followed by TLC. 
After completion of the reaction, The crude mixture was filtered over celite, dried under reduced 
pressure, and directly used in the next step. 
 
2) Following a slightly modified procedure,13 a solution of N-(benzo[b]thiophen-2-ylmethylene)-
1-phenylmethanamine (1.26 g, 5.00 mmol, 1.0 eq) in anhydrous THF (16 mL) was prepared 
under nitrogen. After cooling to -78 °C, a diethyl zinc solution in hexanes (1.0 M, 12.5 mL, 12.5 
mmol, 2.5 eq) and a solution of vinylmagnesium bromide in THF (1.0 M, 12.5 mL, 12.5 mmol, 
2.5 eq) were added. The stirred solution was kept for 1 h at -78 °C, afterwards the cooling bath 
was removed. When the reaction mixture reached room temperature, dilution with 5% w/v aq. 
NaOH (10 mL) and extraction with diethyl ether (3x15 mL) followed. The organic layers were 
collected, dried (MgSO4) and concentrated under vacuum. The crude amine was purified by 
column chromatography (SiO2, Pentane:EtOAc:Et3N 15:1:0.1) to afford the title compound 4p as 
a colourless oil (0.992 g, 3.55 mmol, 71 % yield). 
 
Rf 0.20 (Pentane:EtOAc:Et3N 14:1:0.1).  
1H NMR (400 MHz, Chloroform-d) δ 7.86 – 7.82 (m, 1H, HetArH), 7.75 – 7.69 (m, 1H, 
HetArH), 7.43 – 7.27 (m, 7H, HetArH and ArH), 7.23 – 7.19 (m, 1H, HetArH), 6.04 (ddd, J = 
17.1, 10.1, 7.3 Hz, 1H, CH=CH2), 5.35 (dt, J = 17.1, 1.2 Hz, 1H, CH=CH2), 5.27 (dt, J = 10.1, 
1.1 Hz, 1H, CH=CH2), 4.61 – 4.55 (m, 1H, NCH), 3.87 (s, 2H, PhCH2), 1.85 (bs, 1H, NH). 
13C NMR (101 MHz, Chloroform-d) δ 148.8, 140.1, 139.9, 139.7, 139.6, 128.6, 128.3, 127.2, 
124.2, 124.0, 123.3, 122.6, 120.9, 116.7, 61.1, 51.1. 
IR νmax 3321 (w), 3060 (w), 3028 (w), 2978 (w), 2921 (w), 2839 (w), 1640 (w), 1603 (w), 1495 
(w), 1456 (m), 1414 (w), 1359 (w), 1338 (w), 1310 (w), 1276 (w), 1253 (w), 1189 (w), 1149 (w), 
1127 (w), 1074 (w), 1023 (w), 990 (w), 927 (m), 859 (w), 830 (m), 744 (s). 
HRMS (ESI) calcd for C18H18NS
 + [M+H]+ 280.1154; found 280.1146. 
 
N-Benzyl-2-(((tert-butyldiphenylsilyl)oxy)methyl)prop-2-en-1-amine (4r) 
 
Multisptep procedure: 
1) Following a reported procedure,14 2-methylenepropane-1,3-diol (33) (0.50 mL, 6.1 mmol) was 
dissolved in THF (15 mL), the solution was cooled at 0 °C before the addition of NaH (0.25 g 
60% dispersed in mineral oil, 6.1 mmol, 1.0 eq). After 1 h, TBDPSCl (1.6 mL, 6.1 mmol, 1.0 eq) 
was added and the reaction was stirred at room temperature for 18-20 h. The solution was then 
cooled to 0 °C and quenched with iced water and then extracted with diethyl ether (3 x 50 mL). 
The organic layers are recombined and washed with a saturated solution of K2CO3 (50 mL), brine 
(50 mL) and dried over Na2SO4. Evaporation of the solvent afforded compound 21 (2.0 g, 6.1 
mmol, 99% yield) as a colorless oil which was directly used in the next step. 
 
2) Methanesulfonyl chloride (0.296 mL, 3.83 mmol, 1.25 eq) was added dropwise to a solution of 
2-(((tert-butyldiphenylsilyl)oxy) methyl)prop-2-en-1-ol (1.00 g, 3.06 mmol, 1.0 eq) and Et3N 
                                                 
14 Russo, F.; Wangsell,F.; Saevmarker, J.; Jacobsson, M.; Larhed, M. Tetrahedron 2009, 65, 10047. 
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(0.640 mL, 4.59 mmol, 1.5 eq) in CH2Cl2 (60 mL) at 0 °C. The mixture was stirred at the same 
temperature for 2 h. Saturated Na2CO3 (30 mL) was then added to quench the reaction. After the 
separation of the organic layer, extraction of the aqueous layer with CH2Cl2 (2x20 mL), the 
combined organic layers were washed with brine, dried with MgSO4, concentrated under reduced 
pressure to afford the crude 2-(((tert-butyldiphenylsilyl)oxy)methyl)allyl methanesulfonate, 
which was used directly in the next step.  
 
3) 2-(((Tert-butyldiphenylsilyl)oxy)methyl)allyl methanesulfonate was added dropwise to a 
rapidly stirring neat benzyl amine solution (4.50 g, 42.0 mmol) at 0 °C. The reaction mixture was 
stirred for 15 h at rt. The crude product was purified by column chromatography (SiO2 10:1:0.1 
Pentane:EtOAc:Et3N) to afford the title compound 4r as a pale yellow oil (861 mg, 2.07 mmol, 
68% yield). 
 
Rf 0.75 (Pentane:EtOAc 4:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.71 – 7.65 (m, 4H, ArH), 7.45 – 7.34 (m, 6H, ArH), 7.33 
– 7.22 (m, 5H, ArH), 5.25 (d, J = 1.7 Hz, 1H, C=CH2), 5.07 (d, J = 1.7 Hz, 1H, C=CH2), 4.22 (s, 
2H, TBDPSOCH2), 3.72 (s, 2H, PhCH2), 3.27 (s, 2H, BnNCH2), 1.55 (bs, 1H, NH), 1.06 (s, 9H, 
tBu). 
13C NMR (101 MHz, Chloroform-d) δ 146.4, 140.4, 135.7, 133.7, 129.8, 128.5, 128.3, 127.8, 
127.0, 110.8, 65.8, 53.2, 51.4, 27.0, 19.4. 
IR νmax 3069 (w), 3052 (w), 3029 (w), 2956 (m), 2933 (m), 2890 (w), 2858 (m), 1594 (w), 1458 
(w), 1432 (w), 1390 (w), 1110 (s), 910 (w), 826 (m), 741 (s). 
HRMS (ESI) calcd. for C27H34NOSi
+ [M+H]+ 416.2404; found 416.2412. 
 
4-((Benzylamino)methyl)pent-4-enenitrile (4s) 
 
Multistep procedure: 
1) Following a slightly modified procedure,15 tert-butyl benzylcarbamate (5.00 g, 24.1 mmol, 1.0 
eq) and 3-chloro-2-(chloromethyl)prop-1-ene (34) (3.35 mL, 28.9 mmol, 1.2 eq) were dissolved 
in DMF (25 mL). NaH (1.45 g, 36.2 mmol, 1.5 eq) was added to the clear colorless solution 
which immediately turned to a cloudy mixture. After 6 h, the reaction was quenched by dropwise 
addition of water (100 mL), and then diluted with diethyl ether (ca. 120 mL). The layers were 
separated, and the organic layer was washed successively with water (3x30 mL), then brine (50 
mL), dried (MgSO4), and the solvent was removed under reduced pressure. The residue was 
purified by passing through a short pad of silica, eluting with Pentane:CH2Cl2 1:1 and the crude 
product was directly engaged in the next step.  
 
2) Tert-butyl benzyl(2-(chloromethyl)allyl)carbamate (1.77 g, 6.00 mmol, 1.0 eq) and NaI (2.53 
g, 16.9 mmol, 2.8 eq) were refluxed in 20 mL acetone for 15 h. The reaction mixture was cooled 
down, filtered over Celite and concentrated under reduced pressure. The crude was directly used 
in the next step. 
 
                                                 
15 Aponick, A.; Dietz, A. L.; Pearson, W. H. Eur. J. Org. Chem. 2008, 4264. 
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3) A cooled 2.5 M solution of nBuLi in hexanes (2.74 mL, 6.84 mmol, 2.65 eq) was added to a 
solution of acetonitrile (0.460 mL, 8.81 mmol, 3.41 eq) in THF (12 mL) at -78 °C under nitrogen. 
After 40 min at this temperature, the mixture was warmed to -25 °C and copper(I) iodide (1.69 g, 
8.88 mmol, 3.44 eq) was added. After stirring for 15 min. at -25 °C the brick-colored solution of 
cyanomethylcopper was treated with tert-butyl benzyl(2-(iodomethyl)allyl)carbamate (1.00 g, 
2.58 mmol, 1.0 eq) in THF (8 mL). After 1.5 h at -25 °C, aqueous ammonium chloride (30 mL) 
was added and the product was extracted with ether (2x30 mL). The combined organic phase 
were washed with brine, dried over MgSO4, filtered and concentrated under reduced pressure. 
The crude was directly used in the next step. 
 
4) TFA (1.5 mL) was added to a solution of tert-butyl benzyl(4-cyano-2-
methylenebutyl)carbamate (640 mg, 2.13 mmol) in CH2Cl2 (2.2 mL) at 0 °C. The reaction 
mixture was warmed up to rt and stirred for 3 h. Then 1 N NaOH was added (5 mL) and the 
reaction mixture was stirred for 10 min. Then the layers were separated and the aqueous extracted 
once with CH2Cl2 (20 mL). The combined organic layers were dried over MgSO4, filtered and 
concentrated. The crude product was purified by column chromatography (SiO2, 
Pentane:EtOAc:Et3N 3:1:0.1) to afford the title compound 4s as a pale yellow oil (303 mg, 1.51 
mmol, 31 % overall yield). 
 
Rf 0.20 (Pentane:EtOAc 3:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.36 – 7.31 (m, 4H, ArH), 7.30 – 7.24 (m, 1H, ArH), 5.14 
(s, 1H, C=CH2), 5.01 (s, 1H, C=CH2), 3.77 (s, 2H, PhCH2), 3.25 (s, 2H, BnNCH2), 2.58 – 2.43 
(overlapping signals, 2 m, 4H, CH2CN and CH2CH2CN), 1.77 (s, 1H, NH). 
13C NMR (101 MHz, Chloroform-d) δ 144.3, 140.3, 128.5, 128.2, 127.1, 119.6, 113.4, 53.8, 
53.3, 30.0, 16.3. 
IR νmax 3336 (w), 3078 (w), 3029 (m), 2985 (w), 2922 (m), 2835 (m), 2834 (m), 2247 (w), 2105 
(w), 1737 (m), 1648 (m), 1492 (w), 1450 (m), 1204 (w), 1114 (w), 909 (m), 741 (s). 
HRMS (ESI) calcd. for C13H17N2
+ [M+H]+ 201.1386; found 201.1390. 
 
 
2-Bromo-1-triisopropylsilyl acetylene (5a) 
 
Following a reported procedure,16 triisopropylsilylacetylene (35) (813 mg, 4.45 mmol, 1.00 
equiv) was dissolved in acetone (30 mL). N-bromosuccinimide (925 mg, 5.19 mmol, 1.16 equiv) 
was added, followed by AgNO3 (76 mg, 0.44 mmol, 0.1 equiv). The resulting mixture was stirred 
at room temperature for 3 h and it was then poured onto ice. After ice being allowed to melt, the 
aqueous layer was extracted with pentane (3 x 30 mL). The combined organic layers were dried 
over MgSO4, filtered and concentrated in vacuo to afford pure 2-bromo-1-triisopropylsilyl 
acetylene (5a) (1.16 g, 4.43 mmol, 99%) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 1.20-0.97 (m, 21 H, TIPS). 
13C NMR (100 MHz, CDCl3) δ 83.5, 61.7, 18.5, 11.3. 
Spectra data was consistent with the values reported in literature.16 
 
                                                 
16 Jiang, M. X.; Rawat, M.; Wulff, W. D. J. Am. Chem. Soc., 2004, 126, 5970. 
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((4-Bromo-2-methylbut-3-yn-2-yl)oxy)triisopropylsilane (5b) 
 
 Following a reported procedure,17 2-methylbut-3-yn-2-ol (36) (0.34 mL, 3.5 mmol, 1.0 
equiv.) and 2,6-lutidine (freshly distilled on CaH2, 0.41 mL, 3.5 mmol, 1.0 equiv.) were dissolved 
in CH2Cl2 (12 mL). TIPSOTf (0.94 mL, 3.5 mmol, 1.0 equiv.) was added dropwise to the solution 
at 0 °C. The solution was allowed to warm to rt overnight and then quenched with a saturated 
aqueous NaHCO3 solution and the aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The 
combined organic layers were washed with H2O, dried over MgSO4, filtered and the solvent was 
removed in vacuo. Purification by column chromatography (SiO2, pentane) afforded TIPS-
protected propargyl alcohol 37 as a colorless oil (622 mg, 2.59 mmol, 74% yield), which was 
used directly for the next step. 
 Following a reported procedure,18 propargyl alcohol 37 (603 mg, 2.51 mmol, 1.0 equiv.) 
was dissolved in acetone (17 mL). N-bromosuccinimide (535 mg, 3.01 mmol,1.2 eq) and AgNO3 
(42 mg, 0.25 mmol, 0.1 eq) are added to the resulting solution in this order and the mixture is 
stirred at rt for 6 hours, until complete consumption of the starting material according to TLC. It 
was then poured onto iced water. The aqueous layer was extracted with pentane (3 times) and the 
combined organic extracts were dried over MgSO4, filtered and the solvent removed by 
evaporation under reduced pressure. After purification by column chromatography (SiO2, 
pentane), bromoalkyne 5b was obtained as a colorless oil (733 mg, 2.30 mmol, 91% yield).in 
95% purity as judged by 1H NMR. 
 
1H NMR (400 MHz, CDCl3) δ 1.51 (s, 6 H, Me), 1.18-1.03 (m, 21 H, TIPS). 
13C NMR (100 MHz, CDCl3) δ 85.4, 67.2, 42.7, 32.9, 18.3, 13.0. 
Spectra data was consistent with the values reported in literature.18 
 
(((1-Bromonon-1-yn-3-yl)oxy)methyl)benzene (5c)  
 
Following a slightly modified reported procedure,19 heptaldehyde (38) (1.22 mL, 8.76 mmol, 1.0 
equiv.) was added dropwise to a solution of ethynyl magnesium bromide (0.5 M in THF, 22.8 
mL, 11.4 mmol, 1.3 equiv.) at 0 °C. After 30 min, the cooling bath was removed to reach rt and 
the solution was stirred for further 2 h. The reaction was then quenched by addition of aqueous 
HCl (1.0 M, 15 mL) and the mixture was extracted with Et2O (3 x 20 mL). The combined organic 
layers were washed with brine, dried over MgSO4, filtered and the solvent was removed under 
                                                 
17 Nishimura, T.; Nagaosa, M.; Hayashi, T. Tetrahedron Lett. 2011, 52, 2185. 
18 S. Nicolai, R. Sedigh-Zadeh, J. Waser, J. Org. Chem 2013, 78, 3783. 
19 Buzas, A.; Gagosz, F. J. Am. Chem. Soc. 2006, 128, 12614. 
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reduced pressure. Purification by column chromatography (SiO2, pentane/EtOAc 20/1) afforded 
the corresponding propargyl alcohol as a yellow oil (943 mg, 6.73 mmol, 77% yield).  
 Following a reported procedure,20 the propargyl alcohol (701 mg, 5.00 mmol, 1.0 equiv.) 
was added dropwise to a suspension of NaH (168 mg, 7.00 mmol, 1.4 equiv.) in THF (24 mL). 
The solution was stirred for 2 h and then TBAI (92.3 mg, 0.250 mmol, 0.05 equiv.) and benzyl 
bromide (0.84 mL, 7.0 mmol, 1.4 equiv.) were added sequentially. The resulting mixture was 
stirred overnight and then quenched by slow addition of H2O. The aqueous layer was extracted 
with Et2O (3 x 40 mL) and the combined organic layers were washed with brine, dried over 
MgSO4, filtered and the solvent was removed in vacuo. Purification by column chromatography 
(SiO2, pentane/EtOAc 20/1) afforded the O-benzylated propargyl alcohol 39 as a yellow oil (1.12 
mg, 4.86 mmol, 97% yield). 
 Following a reported procedure,18 propargyl alcohol 39 (1.12 g, 4.86 mmol, 1.0 equiv.) 
was dissolved in acetone (33 mL). N-bromosuccinimide (1.04 g, 5.83 mmol,1.2 eq) and AgNO3 
(83 mg, 0.49 mmol, 0.1 eq) are added to the resulting solution in this order and the mixture is 
stirred at rt for 6 hours, until complete consumption of the starting material according to TLC. It 
was then poured onto iced water. The aqueous layer was extracted with pentane (3 times) and the 
combined organic extracts were dried over MgSO4, filtered and the solvent removed by 
evaporation under reduced pressure. After purification by chromatography column (SiO2, 
Pentane/EtOAc 98/2), bromoalkyne 5c was obtained as a pale yellow oil (1.06 g, 3.43 mmol, 
71% yield).  
 
1H NMR (400 MHz, CDCl3) δ 7.37-7.27 (m, 5 H, Ar H), 4.78 (d, 1 H, J = 11.7 Hz, benzyl CH2), 
4.49 (d, 1 H, J = 11.7 Hz, benzyl CH2), 4.09 (t, 1 H, J = 6.6 Hz, CHO), 1.74 (ddd, 2 H, J = 13.2, 
6.6, 2.0 Hz, CH2), 1.44 (m, 2 H, CH2), 1.35-1.25 (m, 6 H, CH2), 0.88 (t, 3 H, J = 6.7 Hz, Me). 
13C NMR (100 MHz, CDCl3) δ 137.8, 128.4, 128.0, 127.7, 79.5, 70.7, 69.6, 45.1, 35.6, 31.7, 
28.9, 25.2, 22.6, 14.1. 
Spectra data was consistent with the values reported in literature.18 
 
(Bromobuta-1,3-diyn-1-yl)triisopropylsilane (5d) 
 
Following a reported procedure,16 to a mixture of MeOH (1 mL) and H2O (0.5 mL) were 
added n-butylamine (0.88 g, 12 mmol, 3 equiv), 2-methyl-3-butyne-2-ol (0.67 g, 8.0 mmol, 2 
equiv), copper (I) chloride (59 mg, 0.60 mmol, 0.15 equiv) and hydroxyaminehydrochloride (82 
mg, 1.2 mmol, 0.3 equiv) in this order. The alkynyl bromide 5a (4.0 mmol, 0.15 eq) was diluted 
with MeOH (5 mL) and was added dropwise to the mixture. Then the reaction mixture was 
stirred at room temperature for 36 hours. The reaction was quenched with H2O and extracted with 
ether. The organic layer was washed with H2O, brine and dried with MgSO4.and the solvents 
removed under reduced pressure. The crude product was purified by column chromatography 
(SiO2, Pentane:EtOAc 10:1) affording 40 (0.61 g, 2.3 mmol, 58%) as a white solid, which was 
used directly for the next step. 
 Following a reported procedure,16 powdered KOH (0.28 g, 5.0 mmol, 2.2 eq) was added 
in one portion to a solution of the diyne alcohol 40 (2.3 mmol) in benzene (110 mL). The 
                                                 
20 Trost, B. M.; Fandrick, D. R.; Dinh, D. C. J. Am. Chem. Soc. 2005, 127, 14186. 
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resulting mixture was heated and refluxed under N2 until the reaction was complete as monitored 
by TLC. The reaction mixture was cooled to room temperature. Solids were removed by filtration 
through Celite. After concentration, the product was purified by column chromatography (SiO2, 
pentane), affording 41 (0.407 g, 1.97 mmol, 85%) as a clear colorless liquid, which was 
immediately used in the next step. 
 Following a slightly modified procedure,16 diyne 41 was dissolved in acetone (13 mL). N-
bromosuccinimide (421 mg, 2.36 mmol,1.2 eq) and AgNO3 (33 mg, 0.20 mmol, 0.1 eq) were 
added to the resulting solution in this order and the mixture was stirred at rt for 6 hours, until 
complete consumption of the starting material according to TLC. It was then poured onto iced 
water. The aqueous layer was extracted with pentane (3 times) and the combined organic extracts 
were dried over MgSO4, filtered and the solvent removed by evaporation under reduced pressure. 
After purification by column chromatography (SiO2, pentane), bromoalkyne 5d was obtained as a 
pale yellow oil (422 mg, 1.47 mmol, 75% yield, 90% purity as judge by 1H NMR) that turned 
orange upon exposure to air. This bromoalkyne was immediately used for catalysis.21  
 
Rf 0.80 (Pentane).  
1H NMR (400 MHz, CDCl3) δ 1.26-0.97 (m, 21 H, TIPS). 
13C NMR (100 MHz, CDCl3) δ 89.9, 80.9, 66.3, 39.3, 18.7, 11.4. 
IR νmax 2943 (w), 2864 (m), 2238 (m), 2173 (m), 2120 (m), 2091 (m), 1461 (m), 1107 (s), 995 
(s), 881 (s), 662 (w). 
 
 
 
                                                 
21 No high resolution molecular mass could be obtained for this unstable compound. 
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4. Pd-catalyzed tandem hemiaminalization carbo-oxygenation of allylamines. 
 
General procedure A 
A sealed oven-dry 2 mL microwave vial under nitrogen was charged with dry degassed toluene 
(0.80 mL), 1-ethoxy-2,2,2-trifluoroethanol (3) (0.185 mL, 1.35 mmol, 4.5 eq), the allylamine 4 
(0.300 mmol) and the appropriate alkynyl or alkenyl or aryl bromide (1.3 or 2.0 eq). The 
resulting solution was stirred 10-15 min at 50 °C and subsequently transferred via canula to a 
sealed oven-dry 5 mL microwave vial under nitrogen containing cinnamyl(cyclopenta-2,4-dien-
1-yl)palladium (6) (3.5 mg, 0.012 mmol, 4 mol%), DPEPHOS (7a) (9.7 mg, 0.018 mmol, 6 
mol%), cesium carbonate (127 mg, 0.390 mmol, 1.3 eq) and dry degassed toluene (0.70 mL) that 
have been previously premixed at 50 °C for 3 min. The resulting mixture was stirred at 60 °C for 
15 h. The reaction mixture was cooled to 23 °C, concentrated to half its volume and directly 
purified by column chromatography using the indicated solvents.  
NB: the dr was determined by integration of OCHCH2 peaks in the 
1H NMR spectra, unless 
otherwise noted. 
 
General procedure B for -branched allylamines 
A sealed oven-dry 2 mL microwave vial under nitrogen was charged with dry degassed toluene 
(0.80 mL), 1-ethoxy-2,2,2-trifluoroethanol (3) (0.123 mL, 0.900 mmol, 3.0 eq), the allylamine 4 
(0.300 mmol) and (bromoethynyl)triisopropylsilane (5a) (102 mg, 0.390 mmol, 1.3 eq). The 
resulting solution was stirred 10-15 min at 50 °C and subsequently transferred via canula to a 
sealed oven-dry 5 mL microwave vial under nitrogen containing cinnamyl(cyclopenta-2,4-dien-
1-yl)palladium (6) (3.5 mg, 0.012 mmol, 4 mol%), tri(2-furyl)phosphine (7e) (8.4 mg, 0.036 
mmol, 12 mol %), cesium carbonate (127 mg, 0.390 mmol, 1.3 eq) and dry degassed toluene 
(0.70 mL) that have been previously premixed at 50 °C for 3 min. The resulting mixture was 
stirred at 75 °C for 15 h. The reaction mixture was cooled to 23 °C, concentrated to half its 
volume and directly purified by column chromatography using the indicated solvents. 
General procedure C for 1,1-disubstituted olefins 
A sealed oven-dry 2 mL microwave vial under nitrogen was charged with dry degassed toluene 
(0.80 mL), 1-ethoxy-2,2,2-trifluoroethanol (3) (0.062 mL, 0.45 mmol, 1.5 eq), the allylamine 
(0.300 mmol) and the appropriate alkynyl bromide (0.390 mmol, 1.3 eq). The resulting solution 
was stirred 10-15 min at 50 °C and subsequently transferred via canula to a sealed oven-dry 5 mL 
microwave vial under nitrogen containing cinnamyl(cyclopenta-2,4-dien-1-yl)palladium (6) (3.5 
mg, 0.012 mmol, 4 mol %), XANTPhos (7b) (10.4 mg, 0.018 mmol, 6 mol%), cesium carbonate 
(127 mg, 0.390 mmol, 1.3 eq) and dry degassed toluene (0.70 mL) that have been previously 
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premixed at 50 °C for 3 min. The resulting mixture was stirred at 75 °C for 15 h. The reaction 
mixture was cooled to 23 °C, concentrated to half its volume and directly purified by column 
chromatography using the indicated solvents. 
 
N. B.: the signals corresponding to the TIPS in the 13C NMR spectra are often not differentiated 
for the diastereisomers. 
 
3-Benzyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidine (9aa) 
 
Following General Procedure A, the title compound was prepared from 
N-benzylprop-2-en-1-amine (4a) (44.2 mg, 0.300 mmol) and 
(bromoethynyl)triisopropylsilane (5a)  (102 mg, 0.390 mmol). The 
crude oil was purified by column chromatography (SiO2 15:1 to 7:1 
Pentane: CH2Cl2) affording the title compound 9aa (117 mg, 0.275 
mmol, 92% yield, 1:1 dr in the crude 1H NMR) as a yellow oil. 
 
Rf 0.50 (Pentane/CH2Cl2 4/1). 
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 1(A):1(B) δ 7.38 – 7.26 (m, 10H, ArH 
A + B), 4.68 (m, 2H, CHCF3, A + B), 4.41 (m, 1H, OCH A), 4.26 (m, 1H, OCH B), 4.17 (d, J = 
12.9 Hz, 1H, CH2Ph A), 3.99 (d, J = 13.1 Hz, 1H, CH2Ph B), 3.84 (d, J = 13.1 Hz, 1H, CH2Ph B), 
3.72 (d, J = 12.9 Hz, 1H, CH2Ph A), 3.29 (dd, J = 9.3, 5.6 Hz, 1H, CH2N A), 3.14 – 3.06 (m, 2H, 
CH2N B), 2.81 – 2.69 (overlapping signals, 2 m, 2H, CH2CC B, CH2N A), 2.66 (dd, J = 17.0, 4.5 
Hz, 1H, CH2CC A), 2.57 (dd, J = 17.0, 7.2 Hz, 1H, CH2CC A), 2.45 (dd, J = 16.6, 9.1 Hz, 1H, 
CH2CC B), 1.03 (m, 42H, TIPS A and B). 
13C NMR (101 MHz, CDCl3) δ 137.8, 137.6, 128.9, 128.7, 128.7, 128.6, 127.9, 127.7, 123.7 (q, J 
= 285 Hz), 123.3 (q, J = 283 Hz), 103.4, 103.1, 92.9 (q, J = 33.8 Hz), 91.7 (q, J = 33.3 Hz), 83.6, 
83.2, 77.2, 75.8, 59.7, 59.4, 56.7, 56.6, 25.0, 24.9, 18.7, 11.3.22 
IR νmax 3035 (w), 2943 (m), 2893 (w), 2867 (m), 2177 (w), 1678 (w), 1464 (w), 1385 (w), 1384 
(w), 1293 (w), 1170 (s), 1104 (w), 1025 (w), 1002 (w), 885 (w), 734 (w). 
HRMS calcd for C23F3H35NOSi
+ [M+H]+ 426.2435; found 426.2437. 
 
3-(4-Methoxybenzyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidine 
(9ba) 
Following General Procedure A, the title compound was 
prepared from N-(4-methoxybenzyl)prop-2-en-1-amine 
(4b) (53.2 mg, 0.300 mmol) and (bromoethynyl)tri-
isopropylsilane (5a) (102 mg, 0.390 mmol). The crude oil 
was purified by column chromatography (SiO2 15:1 to 3:1 
Pentane:CH2Cl2) affording the title compound 9ba (121 
mg, 0.266 mmol, 89% yield, 1.1:1 dr determined by integration in the crude 1H NMR) as a 
yellow oil. 
 
On larger scale, a slightly different procedure was used: 
An oven-dried 50 mL schlenk equipped with a magnetic stirring bar was cooled under a stream of 
nitrogen and charged with cinnamyl(cyclopenta-2,4-dien-1-yl)palladium (6) (35 mg, 0.12 mmol, 
4 mol%), DPEPHOS (7a) (97 mg, 0.18 mmol, 6 mol%) and cesium carbonate (1.27 g, 3.90 
mmol, 1.3 eq) and sealed with a rubber septum. The schlenk was evacuated and backfilled with 
                                                 
22 The peaks of the TIPS signaled could not be resolved for the diastereoisomers. 
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nitrogen, and this procedure was repeated three times. Then, dry degassed toluene (7.0 mL) was 
added and the resulting mixture was stirred at 50 °C for 10 min.  
A sealed oven-dry 20 mL microwave vial under nitrogen was charged with dry degassed toluene 
(0.80 mL), 1-ethoxy-2,2,2-trifluoroethanol (3) (1.85 mL, 13.5 mmol, 4.5 eq), N-(4-
methoxybenzyl)prop-2-en-1-amine (4b) (532 mg, 3.00 mmol, 1.0 eq) and 
(bromoethynyl)triisopropylsilane (5a) (1.02 g, 3.90 mmol, 1.3 eq). The resulting solution was 
stirred 15 min at 50 °C and subsequently transferred via canula into the schlenk. The resulting 
mixture was stirred at 60 °C for 15 h. The reaction mixture was cooled to 23 °C, filtered over a 
pad of silica, eluting with diethyl ether. The volatiles were removed and the residue was purified 
by column chromatography (SiO2 15:1 to 3:1 Pentane:CH2Cl2) affording the title compound 9ba 
(1.15 g, 2.51 mmol, 84 % yield, 1.1:1 dr determined by integration in the crude 1H NMR) as a 
yellow oil. 
 
Rf 0.20 (Pentane/CH2Cl2 4/1). 
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 1.1(A):1(B) δ 7.29 – 7.21 (m, 4H, ArH 
A + B), 6.91 – 6.84 (m, 4H, ArH A + B), 4.66 (m, 2H, CHCF3, A + B), 4.40 (m, 1H, OCH B), 
4.23 (m, 1H, OCH A), 4.09 (d, J = 12.7 Hz, 1H, CH2Ph B), 3.91 (d, J = 13.0 Hz, 1H, CH2Ph A), 
3.81 (overlapping signals, 2s, 6H, ArOCH3), 3.78 (d, J = 13.0 Hz, 1H, CH2Ph A), 3.67 (d, J = 
12.7 Hz, 1H, CH2Ph B), 3.27 (dd, J = 9.4, 5.6 Hz, 1H, CH2N B), 3.19 – 3.11 (m, 1H, CH2N A), 
3.09 – 3.02 (m, 1H, CH2N A), 2.80 – 2.69 (overlapping signals, 2 m, 2H, CH2CC A, CH2N B), 
2.65 (dd, J = 16.9, 4.5 Hz, 1H, CH2CC B), 2.56 (dd, J = 16.9, 7.3 Hz, 1H, CH2CC B), 2.43 (dd, J 
= 16.5, 9.1 Hz, 1H, CH2CC A), 1.08 – 0.99 (m, 42H, TIPS A and B). 
13C NMR (101 MHz, Chloroform-d) δ 159.3, 159.2, 130.1, 130.0, 129.9, 129.63, 123.8 (q, J = 
284.6 Hz), 123.4 (q, J = 283.2 Hz), 114.1, 114.0, 103.4, 103.2, 92.7 (q, J = 33.6 Hz), 91.6 (q, J = 
33.3 Hz), 83.6, 83.1, 77.3, 75.8, 59.1, 58.7, 56.6, 56.5, 55.4 (2C), 25.1, 24.9, 18.7, 11.3.22 
IR νmax 2944 (m), 2898 (w), 2866 (m), 2177 (w), 1615 (w), 1516 (m), 1465 (w), 1381 (w), 1295 
(m), 1251 (m), 1168 (s), 1106 (w), 1036 (m), 999 (w), 913 (w), 885 (w), 837 (w), 738 (m). 
HRMS calcd for C24F3H37NO2Si
+ [M+H]+ 456.2540; found 456.2530. 
 
2-(Trifluoromethyl)-3-(4-(trifluoromethyl)benzyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-
yl)oxazolidine (9ca) 
Following General Procedure A, the title compound was 
prepared from N-(4-(trifluoromethyl)benzyl)prop-2-en-1-
amine (4c) (64.6 mg, 0.300 mmol) and 
(bromoethynyl)triisopropylsilane (5a) (102 mg, 0.390 
mmol). The crude oil was purified by column 
chromatography (SiO2 15:1 to 9:1 Pentane:CH2Cl2) affording 
the title compound 9ca (141 mg, 0.286 mmol, 95% yield, 1:1 dr determined by integration in the 
crude 1H NMR) as a yellow oil. 
 
Rf 0.60 (Pentane/CH2Cl2 4/1). 
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 1(A):1(B) δ 7.65 – 7.56 (m, 4H, ArH A 
+ B), 7.55 – 7.41 (m, 4H, ArH A + B), 4.75 – 4.60 (m, 2H, CHCF3, A + B), 4.48 – 4.39 (m, 1H, 
OCH B), 4.36 – 4.26 (m, 1H, OCH A), 4.22 (d, J = 13.4 Hz, 1H, CH2Ph B), 4.07 (d, J = 13.7 Hz, 
1H, CH2Ph A), 3.88 (d, J = 13.7 Hz, 1H, CH2Ph A), 3.79 (d, J = 13.4 Hz, 1H, CH2Ph B), 3.28 (dd, 
J = 9.2, 5.6 Hz, 1H, CH2N B), 3.16 – 3.01 (m, 2H, CH2N A), 2.77 (dd, J = 16.6, 4.9 Hz, 1H, 
CH2CC A), 2.73 – 2.63 (overlapping signals, 2 m, 2H, CH2N B + CH2CC B), 2.59 (dd, J = 17.0, 
7.1 Hz, 1H, CH2CC B), 2.48 (dd, J = 16.6, 9.1 Hz, 1H, CH2CC A), 1.11 – 0.92 (m, 42H, TIPS A 
and B). 
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13C NMR (101 MHz, Chloroform-d) δ 142.0, 141.9, 130.2 (q, J = 32.3 Hz), 130.0 (q, J = 32.3 
Hz), 128.9, 128.8, 125.6 (2C), 124.3 (q, J = 272.1 Hz), 124.2 (q, J = 272.1 Hz), 123.7 (q, J = 
283.9 Hz), 123.4 (q, J = 283.2 Hz), 103.2, 102.9, 93.0 (q, J = 33.6 Hz), 91.8 (q, J = 33.4 Hz), 
83.9, 83.4, 77.4, 76.0, 59.2, 58.9, 56.8, 56.7, 25.0, 24.8, 18.7, 18.6, 11.3, 11.2. 
IR νmax 3668 (w), 2975 (m), 2904 (m), 2256 (w), 1701 (w), 1457 (w), 1400 (w), 1388 (w), 1327 
(w), 1291 (w), 1250 (w), 1236 (w), 1172 (w), 1071 (m), 1062 (m), 1054 (m), 907 (s), 732 (s). 
HRMS calcd. for C24H34F6NOSi
+ [M+H]+ 494.2308; found 494.2312. 
 
 
3-(4-Bromobenzyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidine 
(9da) 
Following General Procedure A, the title compound was 
prepared from N-(4-methoxybenzyl)prop-2-en-1-amine (4d) 
(53.2 mg, 0.300 mmol) and (bromoethynyl)triisopropylsilane 
(5a) (102 mg, 0.390 mmol). The crude oil was purified by 
column chromatography (SiO2 15:1 to 7:1 Pentane:CH2Cl2) 
affording the title compound 9da (148 mg, 0.293 mmol, 89% yield, 1:1 dr determined by 
integration in the crude 1H NMR) as a yellow oil. 
 
Rf 0.50 (Pentane/CH2Cl2 4/1).
 
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 1(A):1(B) δ 7.50 – 7.43 (m, 4H, ArH A 
+ B), 7.25 – 7.20 (m, 4H, ArH A + B), 4.69 – 4.60 (m, 2H, CHCF3, A + B), 4.46 – 4.37 (m, 1H, 
OCH B), 4.33 – 4.24 (m, 1H, OCH A), 4.11 (d, J = 13.1 Hz, 1H, CH2Ph B), 3.95 (d, J = 13.4 Hz, 
1H, CH2Ph A), 3.77 (d, J = 13.4 Hz, 1H, CH2Ph A), 3.68 (d, J = 13.1 Hz, 1H, CH2Ph B), 3.27 (dd, 
J = 9.3, 5.6 Hz, 1H, CH2N B), 3.08 (d, J = 6.8 Hz, 2H, CH2N A), 2.76 (dd, J = 16.6, 4.9 Hz, 1H, 
CH2CC A), 2.72 – 2.62 (overlapping signals, 2 m, 2H, CH2CC B, CH2N B), 2.58 (dd, J = 17.0, 
7.1 Hz, 1H, CH2CC B), 2.46 (dd, J = 16.6, 9.0 Hz, 1H, CH2CC A), 1.12 – 0.93 (m, 42H, TIPS A 
and B). 
13C NMR (101 MHz, Chloroform-d) δ 136.9, 136.7, 131.8, 131.7, 130.4, 130.3, 123.7 (q, J = 
284.5 Hz), 123.3 (d, J = 283.3 Hz), 121.7, 121.6, 103.2, 103.0, 92.9 (q, J = 33.9 Hz), 91.7 (q, J = 
33.3 Hz), 83.8, 83.3, 77.3, 75.9, 59.0, 58.7, 56.7, 56.5, 25.0, 24.8, 18.7, 18.6, 11.32, 11.30. 
IR νmax 2942 (m), 2894 (w), 2865 (m), 2176 (w), 1487 (w), 1465 (w), 1407 (w), 1381 (w), 1339 
(w), 1324 (w), 1292 (m), 1239 (w), 1156 (s), 1154 (s), 1103 (m), 1072 (m), 1015 (m), 924 (w), 
883 (m), 859 (w), 835 (w), 806 (w), 741 (w). 
HRMS calcd. for C23H34BrF3NOSi
+ [M+H]+ 504.1540; found 504.1544. 
 
3-(4-Nitrobenzyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidine 
(9ea) 
Following General Procedure A, the title compound was 
prepared from N-(4-nitrobenzyl)prop-2-en-1-amine (4e) 
(0.058 g, 0.30 mmol)and (bromoethynyl)triisopropylsilane 
(5a) (102 mg, 0.390 mmol). The crude oil was purified by 
column chromatography (SiO2 10:1 to 3:1 Pentane:CH2Cl2) 
affording the title compound 9ea (96 mg, 0.20 mmol, 68% yield, 1.2:1 dr determined by 
integration in the crude 1H NMR) as a yellow oil. 
 
Rf 0.35 (Pentane/CH2Cl2 3/1).
 
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 1.2(A):1(B) δ 8.24 – 8.16 (m, 4H, ArH 
A + B), 7.54 (t, J = 8.5 Hz, 4H, ArH A + B), 4.73 – 4.62 (m, 2H, CHCF3, A + B), 4.50 – 4.41 (m, 
S23 
 
1H, OCH A), 4.38 – 4.29 (m, 1H, OCH B), 4.25 (d, J = 14.0 Hz, 1H, CH2Ph A), 4.11 (d, J = 14.2 
Hz, 1H, CH2Ph B), 3.94 (d, J = 14.2 Hz, 1H, CH2Ph B), 3.87 (d, J = 14.0 Hz, 1H, CH2Ph A), 3.31 
(dd, J = 9.2, 5.7 Hz, 1H, CH2N A), 3.13 (m, 1H, CH2N B), 3.05 (m, 1H, CH2N B), 2.77 (dd, J = 
16.6, 4.9 Hz, 1H, CH2CC B), 2.74 – 2.64 (m, 2H, CH2CC A and CH2N A), 2.61 (dd, J = 17.0, 7.0 
Hz, 1H, CH2CC A), 2.49 (dd, J = 16.6, 9.0 Hz, 1H, CH2CC B), 1.03 (m, 42H, TIPS A), 1.00 (m, 
21H, TIPS B). 
13C NMR (101 MHz, Chloroform-d) δ 147.7, 147.6, 145.6, 145.6, 129.2, 129.1, 123.9 (2C), 
123.6 (q, J = 284.7 Hz), 123.2 (q, J = 283.2 Hz), 103.0, 102.8, 93.1 (q, J = 34.0 Hz), 91.9 (q, J = 
33.5 Hz), 83.9, 83.4, 77.5, 76.0, 59.0, 58.8, 56.9, 56.7, 24.9, 24.8, 18.7, 11.3.22 
IR νmax 2944 (m), 2894 (w), 2865 (m), 2177 (w), 1606 (w), 1525 (s), 1465 (w), 1347 (s), 1292 
(m), 1151 (s), 1108 (m), 1058 (w), 1020 (w), 997 (w), 924 (w), 883 (m), 854 (m), 736 (w), 735 
(w). 
HRMS calcd. for C23H34F3N2O3Si
+ [M+H]+ 471.2285; found 471.2281. 
 
4-((2-(Trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidin-3-
yl)methyl)benzaldehyde (9fa) 
 
Following General Procedure A, the title compound was 
prepared from freshly purified 4-
((allylamino)methyl)benzaldehyde (4f) (52.6 mg, 0.300 
mmol) and (bromoethynyl)triisopropylsilane (5a) (102 
mg, 0.390 mmol). The crude oil was purified by column 
chromatography (SiO2 6:1 to 3:1 Pentane:CH2Cl2) 
affording the title compound 9fa (118 mg, 0.260 mmol, 87% yield, 1:1 dr determined by 
integration in the crude 1H NMR) as a yellow oil. 
 
Rf 0.40 (Pentane/CH2Cl2 4/1). 
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 1 (A):1(B) δ 10.00 (s, 2H, CHO A + B), 
7.93 – 7.76 (m, 4H, ArH A + B), 7.53 (dd, J = 8.1, 6.6 Hz, 4H, ArH A + B), 4.72 – 4.63 (m, 2H, 
CHCF3, A + B), 4.48 – 4.39 (m, 1H, OCH B), 4.35 – 4.26 (m, 1H, OCH A), 4.24 (d, J = 13.6 Hz, 
1H, CH2Ph B), 4.08 (d, J = 13.9 Hz, 1H, CH2Ph A), 3.91 (d, J = 13.9 Hz, 1H, CH2Ph A), 3.82 (d, 
J = 13.6 Hz, 1H, CH2Ph B), 3.30 (dd, J = 9.2, 5.6 Hz, 1H, CH2N B), 3.15 – 3.03 (m, 2H, CH2N 
A), 2.81 – 2.63 (overlapping signals, 3 m, 3H, CH2CC A, CH2N B and CH2CC B), 2.59 (dd, J = 
17.0, 7.0 Hz, 1H, CH2CC B), 2.47 (dd, J = 16.6, 9.0 Hz, 1H, CH2CC A), 1.10 – 0.91 (m, 42H, 
TIPS A and B). 
13C NMR (101 MHz, Chloroform-d) δ 192.0, 191.9, 145.0, 144.8, 136.0, 135.9, 130.1 (2C), 
129.1, 129.0, 123.8 (q, J = 284.6 Hz), 123.4 (q, J = 283.2 Hz), 103.1, 102.8, 93.0 (q, J = 33.8 
Hz), 91.8 (q, J = 33.4 Hz), 83.8, 83.3, 77.4, 75.9, 59.4, 59.1, 56.8, 56.7, 24.9, 24.8, 18.7, 18.6, 
11.3, 11.2. 
IR νmax 2944 (m), 2893 (w), 2865 (m), 2734 (w), 2256 (w), 2176 (w), 1703 (m), 1609 (w), 1581 
(w), 1465 (w), 1428 (w), 1384 (w), 1293 (m), 1239 (w), 1207 (m), 1166 (s), 1057 (w), 1020 (w), 
997 (w), 912 (m), 884 (m), 851 (w), 828 (w), 783 (w), 735 (s). 
HRMS calcd. for C24H35F3NO2Si
+ [M+H]+ 454.2384; found 454.2384. 
 
3-(2-chlorobenzyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidine 
(9ga) 
Following General Procedure A, the title compound was 
prepared from N-(2-chlorobenzyl)prop-2-en-1-amine (4g) (54.5 
mg, 0.300 mmol) and (bromoethynyl)triisopropylsilane (5a) 
(102 mg, 0.390 mmol). The crude oil was purified by column 
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chromatography (SiO2 15:1 to 10:1 Pentane:CH2Cl2) affording the title compound 9ga (120 mg, 
0.261 mmol, 87% yield, 1.3:1 dr determined by integration in the crude 1H NMR) as a yellow oil. 
 
Rf 0.60 (Pentane/CH2Cl2 4/1). 
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 1.3(A):1(B) δ 7.59 – 7.50 (m, 2H, ArH 
A + B), 7.40 – 7.34 (m, 2H, ArH A + B), 7.32 – 7.19 (m, 4H, ArH A + B), 4.78 – 4.70 (m, 2H, 
CHCF3, A + B), 4.49 – 4.41 (m, 1H, OCH B), 4.38 – 4.28 (m, 1H, OCH A), 4.17 (d, J = 14.1 Hz, 
1H, CH2Ph B), 4.08 – 4.02 (overlapping signals, m, 3H, CH2Ph A + CH2PhB), 3.37 (dd, J = 9.2, 
5.6 Hz, 1H, CH2N B), 3.19 – 3.06 (m, 2H, CH2N A), 2.85 – 2.75 (overlapping signals, 2 m, 2H, 
CH2CC A, CH2N B), 2.69 (dd, J = 16.9, 4.5 Hz, 1H, CH2CC B), 2.60 (dd, J = 16.9, 7.3 Hz, 1H, 
CH2CC B), 2.49 (dd, J = 16.6, 9.0 Hz, 1H, CH2CC A), 1.13 – 0.94 (m, 42H, TIPS A and B). 
13C NMR (101 MHz, Chloroform-d) δ 135.5, 135.4, 133.9, 133.8, 130.6, 130.5, 129.7, 129.6, 
128.9, 128.8, 127.1, 127.0, 123.8 (q, J = 284.6 Hz), 123.5 (q, J = 283.2 Hz), 103.3, 103.0, 93.4 
(q, J = 33.8 Hz), 92.0 (q, J = 33.4 Hz), 83.7, 83.2, 77.4, 75.9, 56.8 (2C), 56.6, 56.1, 25.0, 24.9, 
18.7, 11.3.22 
IR νmax 3069 (w), 2944 (m), 2894 (w), 2866 (m), 2177 (w), 1466 (m), 1382 (w), 1336 (w), 1324 
(w), 1292 (m), 1240 (w), 1151 (s), 1035 (m), 997 (w), 924 (w), 883 (m), 858 (w), 752 (m). 
HRMS calcd for C23H34ClF3NOSi
+ [M+H]+ 460.2045; found 460.2048. 
 
3-(Furan-2-ylmethyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidine 
(9ha) 
Following General Procedure A, the title compound was prepared 
from N-(furan-2-ylmethyl)prop-2-en-1-amine (4h) (41 mg, 0.30 
mmol) and (bromoethynyl)triisopropylsilane (5a) (102 mg, 0.390 
mmol). The crude oil was purified by column chromatography 
(SiO2 20:1 to 7:1 Pentane:CH2Cl2) affording the title compound 
9ha (115 mg, 0.282 mmol, 92% yield, 1:1 dr determined by 
integration of the CF3CH protons in the crude 
1H NMR) as a yellow oil. 
 
Rf 0.45 (Pentane/ CH2Cl2 5/1). 
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 1(A):1(B) δ 7.40 (dd, J = 2.0, 0.8 Hz, 
2H, HetArH A + B), 6.36 – 6.32 (m, 2H, HetArH A + B), 6.28 – 6.24 (m, 2H, HetArH A + B), 
4.80 (q, J = 5.2 Hz, 1H, CHCF3 A), 4.73 (q, J = 5.0 Hz, 1H, CHCF3 B), 4.45 – 4.37 (m, 1H, OCH 
B), 4.02 (d, J = 14.6 Hz, 1H, CH2PhB), 3.96 (d, J = 14.9 Hz, 1H, CH2Ph A), 3.92 – 3.82 
(overlapping signals, 3m, 3H, CH2Ph A + CH2PhB and OCH A), 3.43 (dd, J = 9.3, 5.7 Hz, 1H, 
CH2N B), 3.31 (ddd, J = 11.8, 5.8, 1.2 Hz, 1H, CH2N A), 3.12 (ddd, J = 11.8, 8.4, 1.3 Hz, 1H, 
CH2N A), 2.87 (m, 1H, CH2N B), 2.71 (dd, J = 16.6, 4.7 Hz, 1H, CH2CC A + B), 2.65 
(overlapping signals, 2 m, 2H, CH2CC A + B), 2.43 – 2.34 (overlapping signals, 2 m, 2H, CH2CC 
A + B), 1.10 – 0.97 (m, 42H, TIPS A + B). 
13C NMR (101 MHz, Chloroform-d) δ 151.0, 150.9, 143.0, 142.9, 123.8 (q, J = 284.4 Hz), 123.4 
(q, J = 282.9 Hz), 110.6, 110.4, 109.5, 109.3, 103.3, 103.1, 92.3 (q, J = 33.9 Hz), 90.7 (q, J = 
33.5 Hz), 83.5, 83.1, 77.4, 76.3, 56.5, 56.3, 51.2, 50.1, 25.0, 24.8, 18.7, 11.3.22 
IR νmax 2944 (m), 2895 (w), 2866 (m), 2177 (w), 1504 (w), 1465 (w), 1386 (w), 1324 (w), 1293 
(m), 1150 (s), 1077 (w), 1016 (m), 916 (w), 884 (m), 857 (w), 737 (s). 
HRMS calcd for C21H33F3NO2Si
+ [M+H]+ 416.2227; found 416.2229. 
 
 
3-Methyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidine (9ia) 
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Following General Procedure A, the title compound was prepared from N-
methylprop-2-en-1-amine (4i) (21.3 mg, 0.300 mmol) and 
(bromoethynyl)triisopropylsilane (5a) (102 mg, 0.390 mmol). The crude 
oil (2:1 dr determined by integration of the NCH2 protons in the crude 
1H 
NMR) was purified by column chromatography (SiO2 10:1 to 3:1 
Pentane:CH2Cl2) affording the title compound 9ia (78 mg, 0.22 mmol, 74% yield, 1.9:1 dr 
determined by integration of the NCH2 protons in the 
1H NMR) as a yellow oil. 
 
Rf 0.20 (Pentane/CH2Cl2 4/1).
 
1H NMR (400 MHz, Chloroform-d) mixture of diastereoisomers 1.9(A):1(B) δ 4.48 – 4.24 (m, 
4H, CHCF3 and OCH A + B), 3.46 (dd, J = 8.8, 5.1 Hz, 2H, CH2N A), 3.20 (dd, J = 11.1, 6.1 Hz, 
1H, CH2N B), 2.97 (dd, J = 11.1, 6.0 Hz, 1H, CH2N B), 2.76 – 2.63 (overlapping signals, 3 m, 
3H, CH2N A and CH2CC A + B), 2.61 – 2.47 (overlapping signals, 4 m, 8H, CH2CC A + B and 
CH3 A + B), 1.15 – 0.93 (m, 42H, TIPS A and B). 
13C NMR (101 MHz, Chloroform-d) δ 123.8 (d, J = 283.9 Hz), 123.3 (d, J = 282.9 Hz), 103.5, 
102.9, 94.3 (q, J = 33.6 Hz), 93.0 (q, J = 33.2 Hz), 83.7, 83.0, 77.4, 76.1, 59.5, 58.9, 42.4, 41.3, 
25.3, 24.5, 18.7, 18.7, 11.3.22 
IR νmax 2944 (w), 2894 (w), 2893 (w), 2866 (w), 2815 (w), 2814 (w), 2177 (w), 1464 (w), 1295 
(w), 1249 (w), 1224 (w), 1154 (s), 1097 (w), 1070 (w), 1028 (w), 1000 (w), 911 (m), 884 (w), 
855 (w), 735 (s). 
HRMS calcd. for C17H31F3NOSi
+ [M+H]+ 350.2122; found 350.2115.  
 
3-Allyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidine (9ja) 
 
Following General Procedure A, the title compound was prepared 
from diallylamine (4j) (37.3 µl, 0.300 mmol) and 
(bromoethynyl)triisopropylsilane (5a) (102 mg, 0.390 mmol). The 
crude oil was purified by column chromatography (SiO2 15:1 to 
8:1 Pentane:CH2Cl2) affording the title compound  9ja (109 mg, 
0.290 mmol, 97 % yield, 1:1 dr determined by integration in the crude 1H NMR) as a yellow oil. 
 
Rf 0.40 (Pentane/ CH2Cl2 4/1). 
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 1(A):1(B) δ 5.95 – 5.79 (m, 2H, 
CH2=CH A + B), 5.28 – 5.14 (m, 4H, CH2=CH A + B), 4.64 (q, J = 5.5 Hz, 1H, CHCF3 A), 4.58 
(q, J = 5.1 Hz, 1H, CHCF3 B), 4.46 – 4.36 (m, 1H, OCH A), 4.29 – 4.18 (m, 1H, OCH B), 3.59 – 
3.51 (m, 1H, CH2CH=CH2 B), 3.48 – 3.24 (m, 4H, CH2N B and CH2CH=CH2 A + B), 3.22 – 3.14 
(m, 1H, CH2N A), 3.14 – 3.05 (m, 1H, CH2N A), 2.81 – 2.72 (m, 2H, CH2N B and CH2CC A), 
2.69 (dd, J = 16.9, 4.4 Hz, 1H, CH2CC B), 2.56 (dd, J = 16.9, 7.6 Hz, 1H, CH2CC B), 2.43 (dd, J 
= 16.5, 9.1 Hz, 1H, CH2CC A), 1.13 – 0.93 (m, 42H, TIPS A and B). 
13C NMR (101 MHz, Chloroform-d) δ 134.5, 134.4, 123.8 (q, J = 284.5 Hz), 123.4 (q, J = 282.9 
Hz), 119.0, 118.5, 103.3, 103.1, 92.7 (q, J = 33.7 Hz), 91.3 (q, J = 33.2 Hz), 83.6, 83.2, 77.4, 
75.9, 58.9, 58.2, 56.8, 56.6, 25.0 (2C), 18.7, 18.7, 11.3.22 
IR νmax 2944 (m), 2896 (w), 2866 (m), 2177 (w), 1604 (w), 1526 (w), 1465 (w), 1346 (m), 1292 
(m), 1167 (s), 1150 (s), 1108 (m), 1058 (w), 1022 (m), 996 (m), 926 (w), 883 (m), 853 (m), 737 
(w). 
HRMS calcd. for C19H33F3NOSi
+ [M+H]+ 376.2278; found 376.2270. 
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3-Benzyl-4-methyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidine 
(9ka) 
Following General Procedure B, the title compound was prepared from 
N-benzylbut-3-en-2-amine (4ka) (48.4 mg, 0.300 mmol) and 
(bromoethynyl)triisopropylsilane (5a) (102 mg, 0.390 mmol, 1.3 eq). 
The crude oil (18.9:1.3:1 dr determined by integration in the crude 19F 
NMR) was purified by column chromatography (SiO2 15:1 to 7:1 
Pentane:CH2Cl2) affording the title compound 9ka (107 mg, 0.243 mmol, 81 % yield, 21.8:1.1:1 
dr determined by integration in the 19F NMR) as a yellow oil. 
 
Rf 0.50 (Pentane/ CH2Cl2 4/1). 
1H NMR (400 MHz, CDCl3) major diastereoisomer δ 7.42 – 7.26 (m, 5H, ArH), 4.69 (q, J = 5.0 
Hz, 1H, CHCF3), 4.08 (d, J = 13.9 Hz, 1H, CH2Ph), 3.97 – 3.87 (m, 2H, OCH and CH2Ph), 3.13 
– 3.02 (m, 1H, NCH), 2.62 (d, J = 5.3 Hz, 2H, CH2CC), 1.14 – 0.96 (m, 24H, TIPS and Me). 
13C NMR (101 MHz, CDCl3) major diastereoisomer δ 137.9, 129.0, 128.5, 127.6, 123.8 (d, J = 
284.7 Hz), 103.1, 91.5 (q, J = 33.3 Hz), 83.7, 83.4, 64.3, 58.4, 23.8, 18.8, 18.1, 11.4. 
IR νmax 3032 (w), 2942 (m), 2897 (w), 2866 (m), 2177 (w), 1462 (w), 1383 (w), 1320 (w), 1292 
(m), 1149 (s), 1085 (w), 1020 (w), 994 (w), 883 (w), 858 (w), 732 (w). 
HRMS calcd for C24H37F3NOSi
+ [M+H]+ 440.2591; found 440.2599.  
 
Stereochemistry assigned by ROESY on compound 13. 
 
 
 
 
 
 
 
3-Benzyl-4-isobutyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidine 
(9la) 
Following General Procedure B, the title compound was prepared from 
N-benzyl-5-methylhex-1-en-3-amine (4l) (61.0 mg, 0.300 mmol) and 
(bromoethynyl)triisopropylsilane (5a) (102 mg, 0.390 mmol, 1.3 eq). 
The crude oil (>20:1 dr determined by integration in 19F NMR) was 
purified by column chromatography (SiO2 15:1 to 7:1 Pentane:CH2Cl2) 
affording the title compound 9la (103 mg, 0.214 mmol, 71% yield, 
>20:1 dr determined by integration in 19F NMR) as a yellow oil. 
 
Rf 0.60 (Pentane/CH2Cl2 6/1). 
1H NMR (400 MHz, Chloroform-d) δ 7.37 – 7.27 (m, 5H, ArH), 4.72 (q, J = 5.5 Hz, 1H, 
CHCF3), 4.08 – 3.96 (overlapping signals, 3H, CH2Ph and OCH), 3.30 (app q, J = 6.6 Hz, 1H, 
NCH), 2.65 (dd, J = 17.2, 6.2 Hz, 1H, CCCH2), 2.59 (dd, J = 17.2, 4.3 Hz, 1H, CCCH2), 1.69 – 
1.57 (m, 1H, (CH3)2CH), 1.45 – 1.29 (m, 2H, (CH3)2CHCH2), 1.16 – 1.04 (m, 21H, TIPS), 0.83 
(app t, J = 6.1 Hz, 6H, CH3). 
13C NMR (101 MHz, CDCl3) δ 138.2, 129.3, 128.5, 127.8, 123.5 (q, J = 284.9 Hz), 103.5, 92.5 
(q, J = 33.6 Hz), 83.6, 83.0, 66.3, 60.8, 44.1, 25.3, 25.1, 23.0, 22.9, 18.8, 11.4. 
IR νmax 3032 (w), 2952 (m), 2900 (w), 2867 (w), 2176 (w), 1464 (w), 1386 (w), 1370 (w), 1291 
(w), 1170 (s), 1149 (s), 1082 (w), 1020 (w), 992 (w), 910 (m), 884 (w), 859 (w), 735 (s).  
HRMS calcd for C27H43F3NOSi
+ [M+H]+ 482.3061; found 482.3061. 
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Stereochemistry assigned by ROESY. 
 
 
3-Benzyl-4-((benzyloxy)methyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-
yl)oxazolidine (9ma) 
Following General Procedure B with cinnamyl(cyclopenta-2,4-dien-
1-yl)palladium (6) (6.9 mg, 0.024 mmol, 8 mol %), tri(2-
furyl)phosphine (7e) (17 mg, 0.072 mmol, 24 mol%), the title 
compound was prepared from N-benzyl-1-(benzyloxy)but-3-en-2-
amine (4m) (80.0 mg, 0.300 mmol). and 
(bromoethynyl)triisopropylsilane (5a) (102 mg, 0.390 mmol, 1.3 eq). The crude oil (29.4:1.5:1 dr 
determined by integration in the crude 19F NMR) was purified by column chromatography (SiO2 
10:1 Pentane:CH2Cl2) affording the title compound 9ma (102 mg, 0.187 mmol, 62% yield, 
35.6:1.3:1 dr determined by integration in 19F NMR) as a yellow oil. 
 
Rf 0.35 (Pentane/CH2Cl2 4/1). 
1H NMR (400 MHz, Chloroform-d) δ 7.34 – 7.24 (m, 8H, ArH), 7.23 – 7.19 (m, 2H, ArH), 4.78 
(q, J = 5.1 Hz, 1H, CHCF3), 4.35 (s, 2H, OCH2Ph), 4.26 – 4.20 (m, 1H, OCH), 4.09 (d, J = 13.4 
Hz, 1H, NCH2Ph), 4.01 (d, J = 13.4 Hz, 1H, NCH2Ph), 3.42 – 3.32 (overlapping signals, 2 m, 2H, 
NCH and BnOCH2), 3.27 – 3.19 (m, 1H, BnOCH2), 2.77 (dd, J = 17.3, 5.1 Hz, 1H, CCCH2), 2.63 
(dd, J = 17.3, 4.3 Hz, 1H, CCCH2), 1.18 – 1.03 (m, 21H, TIPS). 
13C NMR (101 MHz, CDCl3) major diastereoisomer only δ 138.2, 138.1, 129.1, 128.6, 128.5, 
127.8, 127.7, 127.5, 123.6 (q, J = 284.8 Hz), 103.9, 92.5 (q, J = 33.4 Hz), 83.4, 81.8, 73.3, 72.4, 
66.8, 60.0, 25.2, 18.8, 11.5. 
IR νmax 3033 (w), 2943 (m), 2899 (w), 2865 (m), 2817 (w), 2175 (w), 1730 (w), 1669 (w), 1496 
(w), 1460 (w1374 (w), 1290 (m), 1261 (w), 1253 (w), 1170 (s), 1145 (s), 1082 (m), 1020 (w), 
913 (w), 885 (w), 861 (w), 853 (w), 843 (w), 736 (m). 
HRMS calcd for C31H43F3NO2Si
+ [M+H]+ 546.3010; found 546.3031. 
Stereochemistry assigned by analogy. 
 
3-Benzyl-4-phenyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidine 
(9na) 
Following General Procedure B with cinnamyl(cyclopenta-2,4-dien-1-
yl)palladium (6) (6.9 mg, 0.024 mmol, 8 mol %), tri(2-
furyl)phosphine (7e) (17 mg, 0.072 mmol, 24 mol%), the title 
compound was prepared from N-benzyl-1-phenylprop-2-en-1-amine 
(4n) (67.0 mg, 0.300 mmol) and (bromoethynyl)triisopropylsilane 
(5a) (102 mg, 0.390 mmol, 1.3 eq). The crude oil (11.4:1.2:1 dr 
determined by integration in the crude 1H NMR) was purified by 
column chromatography (SiO2 15:1 to 10:1 Pentane:CH2Cl2) affording the title compound 9na 
(136 mg, 0.271 mmol, 90% yield, 12.5:1.3:1 dr determined by integration in the 1H NMR) as a 
yellow oil. 
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Rf 0.50 (Pentane/CH2Cl2 5/1). 
1H NMR (400 MHz, CDCl3) major diastereoisomer  δ 7.42 – 7.37 (m, 2H, ArH), 7.36 – 7.15 (m, 
6H, ArH), 7.13 – 7.07 (m, 2H, ArH), 4.85 (q, J = 4.8 Hz, 1H, CHCF3), 4.15 – 4.05 (overlapping 
signals, 2 m, 2H, OCH and NCH), 3.95 (d, J = 13.9 Hz, 1H, CH2Ph), 3.90 (d, J = 13.9 Hz, 1H, 
CH2Ph), 2.69 (dd, J = 17.7, 3.7 Hz, 1H, CH2CC), 2.40 (dd, J = 17.7, 3.9 Hz, 1H, CH2CC), 1.12 – 
0.95 (m, 21H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 137.3, 135.7, 129.8, 128.8, 128.3, 128.3, 128.0, 127.6, 124.1 (d, J 
= 285.3 Hz), 103.0, 89.8 (q, J = 33.4 Hz), 83.9, 83.7, 70.7, 56.1, 21.9, 18.8, 11.4. 
IR νmax 2936 (m), 2863 (m), 2175 (w), 1462 (w), 1291 (w), 1152 (s), 915 (m), 821 (w), 746 (s). 
HRMS calcd for C29H39F3NOSi
+ [M+H]+ 502.2748; found 502.2750. 
 
Stereochemistry assigned by ROESY. 
 
 
3-Benzyl-4-(furan-2-yl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-
yl)oxazolidine (9oa) 
Following General Procedure B with cinnamyl(cyclopenta-2,4-dien-1-
yl)palladium (6) (6.9 mg, 0.024 mmol, 8 mol %), tri(2-furyl)phosphine 
(7e) (17 mg, 0.072 mmol, 24 mol%), the title compound was prepared 
from N-benzyl-1-(furan-2-yl)prop-2-en-1-amine (4o) (0.064 g, 0.30 
mmol) and (bromoethynyl)triisopropylsilane (5a) (102 mg, 0.390 
mmol, 1.3 eq). The crude oil (9.0:4:1:1 dr determined by integration in 
the crude 1H NMR) was purified by column chromatography (SiO2 :1 
Pentane:CH2Cl2) affording the title compound 9oa (0.119 g, 0.242 mmol, 81% yield, 8.4:4:2:1 dr 
determined by integration in the 1H NMR) as a yellow oil. 
 
Rf 0.55 (Pentane/CH2Cl2 4/1). 
1H NMR (400 MHz, CDCl3) for the two main diastereoisomers 2(A):1(B)  δ 7.48 (d, J = 1.8 Hz, 
1H, HetArH B), 7.36 – 7.13 (m, 11H, ArH A + B), 6.38 – 6.35 (m, 1H, HetArH B), 6.21 (m, 1H, 
HetArH, A), 6.17 (m, 1H, HetArH, A), 6.12 – 6.10 (m, 1H, HetArH B), 4.99 (q, J = 4.3 Hz, 1H, 
CHCF3 B), 4.79 (q, J = 4.9 Hz, 1H, CHCF3 A), 4.64 (m, 1H, OCH B), 4.45 – 4.37 (m, 1H, OCH 
A), 4.29 (d, J = 4.5 Hz, 1H, NCH B), 4.20 (d, J = 8.6 Hz, 1H, NCH A), 4.03 (d, J = 13.9 Hz, 1H, 
CH2Ph A), 4.02 (d, J = 13.7 Hz, 1H, CH2Ph B), 3.97 (d, J = 13.9 Hz, 1H, CH2Ph A), 3.39 (d, J = 
13.7 Hz, 1H, CH2Ph B), 2.73 (dd, J = 17.5, 4.5 Hz, 1H, CH2CC A), 2.50 (overlapping signals, 2 
m, 2H, CH2CC A + B), 2.00 (dd, J = 16.6, 9.0 Hz, 1H, CH2CC B), 1.13 – 1.02 (m, 21H, TIPS A), 
1.02 – 0.92 (m, 21H, TIPS B). 
13C NMR (101 MHz, CDCl3) for the two main diastereoisomers δ 150.8, 150.4, 143.2, 142.7, 
137.9, 136.4, 129.2 (2C), 128.4, 128.4, 127.6, 127.4, 124.1 (q, J = 285.0 Hz), 123.8 (q, J = 284.8 
Hz), 112.2, 110.4, 110.2, 108.8, 103.0, 102.7, 90.5 (q, J = 33.9 Hz), 89.9 (q, J = 33.3 Hz), 83.9, 
83.1, 80.8, 80.5, 65.0, 59.9, 57.3, 52.0, 23.0, 21.8, 18.6, 11.3. 
IR νmax 2943 (w), 2890 (w), 2865 (m), 2178 (w), 1713 (w), 1463 (w), 1291 (m), 1151 (s), 1013 
(w), 911 (m), 884 (w), 854 (w), 735 (s). 
HRMS calcd for C27H37F3NO2Si
+ [M+H]+ 492.2540; found 492.2531. 
Stereochemistry assigned by analogy. 
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4-(Benzo[b]thiophen-2-yl)-3-benzyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-
yl)oxazolidine (9pa) 
Following General Procedure B with cinnamyl(cyclopenta-2,4-dien-
1-yl)palladium (6) (6.9 mg, 0.024 mmol, 8 mol %) and tri(2-
furyl)phosphine (7e) (17.0 mg, 0.072 mmol, 24 mol%), the title 
compound was prepared from 1-(benzo[b]thiophen-2-yl)-N-
benzylprop-2-en-1-amine (4p) (84 mg, 0.30 mmol) and 
(bromoethynyl)triisopropylsilane (102 mg, 0.390 mmol, 1.3 eq). 
The crude oil (4:1 dr determined by integration in the crude 19F 
NMR) was purified by column chromatography (SiO2 14:1 
Pentane:CH2Cl2) affording the title compound 9pa (121 mg, 0.217 mmol, 72% yield, 12:1 dr 
determined by integration in the 19F NMR) as a yellow oil. 
 
Rf 0.55 (Pentane/CH2Cl2 6/1). 
1H NMR (400 MHz, CDCl3) major diastereoisomer δ 7.85 – 7.79 (m, 1H, HetArH), 7.73 – 7.68 
(m, 1H, HetArH), 7.38 – 7.20 (m, 8H, ArH), 4.85 (q, J = 4.7 Hz, 1H, CHCF3), 4.50 (d, J = 8.6 
Hz, 1H, CHN), 4.34 – 4.28 (m, 1H, OCH), 4.10 (d, J = 14.1 Hz, 1H, CH2Ph), 3.98 (d, J = 14.1 
Hz, 1H, CH2Ph), 2.76 (dd, J = 17.7, 4.4 Hz, 1H, CH2CC), 2.56 (dd, J = 17.7, 4.2 Hz, 1H, 
CH2CC), 1.11 – 0.97 (m, 21H, TIPS). 
13C NMR (101 MHz, CDCl3) major diastereoisomer δ 143.1, 140.0, 139.7, 135.3, 129.9, 128.5, 
127.9, 124.5, 124.4, 123.8 (q, J = 285.3 Hz), 123.4, 123.1, 122.7, 102.3, 89.4 (q, J = 33.9 Hz), 
84.2, 82.8, 66.7, 55.7, 22.3, 18.8, 11.3. 
IR νmax 3064 (w), 3033 (w), 2944 (m), 2894 (w), 2866 (m), 2178 (w), 1727 (w), 1658 (w), 1601 
(w), 1497 (w), 1463 (w), 1380 (w), 1350 (w), 1293 (m), 1247 (w), 1153 (s), 1078 (w), 1025 (w), 
1004 (w), 974 (w), 913 (w), 885 (w), 854 (w), 746 (m). 
HRMS calcd for C31F3H39NOSSi
+ [M+H]+ 558.2468; found 558.2460. 
Stereochemistry assigned by analogy. 
 
3-Benzyl-5-methyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidine 
(9qa) 
Following General Procedure C, the title compound was prepared from 
N-benzyl-2-methylprop-2-en-1-amine (4q) (48.4 mg, 0.300 mmol) and 
(bromoethynyl)triisopropylsilane (5a) (102 mg, 0.390 mmol). The crude 
oil (>20:1 dr determined by integration in the crude 1H NMR) was 
purified by column chromatography (SiO2 15:1 to 7:1 Pentane:CH2Cl2) 
affording the title compound 9qa (116 mg, 0.264 mmol, 88 % yield, > 20:1 dr determined by 1H 
NMR) as a pale yellow oil.  
 
Rf 0.60 (Pentane/CH2Cl2 4/1).  
1H NMR (400 MHz, Chloroform-d) δ 7.37 – 7.26 (m, 5H, ArH), 4.71 (q, J = 4.7 Hz, 1H, 
CHCF3), 4.15 (d, J = 13.1 Hz, 1H, CH2Ph), 3.78 (d, J = 13.2 Hz, 1H, CH2Ph), 3.08 (d, J = 10.2 
Hz, 1H, CH2N), 2.97 (d, J = 10.2 Hz, 1H, CH2N), 2.60 (d, J = 16.8 Hz, 1H, CH2CC), 2.53 (d, J = 
16.8 Hz, 1H, CH2CC), 1.44 (s, 3H, CH3), 1.04 (m, 21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) δ 138.1, 128.62, 128.58, 127.6, 123.6 (q, J = 284), 104.5, 
92.3 (q, J = 33.4 Hz), 83.9, 83.3, 60.6, 58.7, 32.3, 25.1, 18.7, 11.4. 
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IR νmax  3086 (w), 3066 (w), 3032 (w), 2943 (m), 2895 (w), 2866 (m), 2176 (w), 2175 (w), 1493 
(w), 1462 (w), 1381 (w), 1294 (m), 1239 (w), 1209 (w), 1157 (s), 1100 (m), 1077 (w), 1036 (w), 
994 (w), 915 (w), 884 (w), 857 (w), 722 (w). 
HRMS (ESI) calcd for C24F3H37NOSi
+ [M+H]+ 440.2591; found 440.2599. 
 
Stereochemistry was assigned by 2D ROESY NMR experiment. 
 
 
3-Benzyl-5-methyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidine 
(9ra) 
Following General Procedure C, the title compound was prepared 
from  N-benzyl-2-(((tert-butyldiphenylsilyl)oxy)methyl)prop-2-en-1-
amine (4r) (125 mg, 0.300 mmol) and 
(bromoethynyl)triisopropylsilane (5a) (102 mg, 0.390 mmol, 1.3 eq). 
The crude oil (> 20:1 dr determined by integration in the crude 1H 
NMR) was purified by column chromatography (SiO2 15:1 to 7:1 
Pentane:CH2Cl2) affording the title compound 9ra (106 mg, 0.153 mmol, 51% yield, >20:1 dr 
determined by 1H NMR) as a pale yellow oil.  
 
Rf 0.55 (Pentane/CH2Cl2 4/1).  
1H NMR (400 MHz, Chloroform-d) δ 7.71 – 7.61 (m, 4H, ArH), 7.49 – 7.27 (m, 11H, ArH), 4.80 
(q, J = 4.4 Hz, 1H, CHCF3), 4.19 (d, J = 13.1 Hz, 1H, CH2Ph), 3.84 (d, J = 10.3 Hz, 1H, 
CH2OSi), 3.78 (d, J = 13.1 Hz, 1H, CH2Ph), 3.64 (d, J = 10.3 Hz, 1H, CH2OSi), 3.14 (d, J = 10.3 
Hz, 1H, CH2N), 3.09 (d, J = 10.3 Hz, 1H, CH2N), 3.00 (d, J = 16.9 Hz, 1H, CH2CC), 2.67 (d, J = 
17.0 Hz, 1H, CH2CC), 1.09 (m, 21H, TIPS), 1.05 (s, 9H, t-Bu). 
13C NMR (101 MHz, Chloroform-d) δ 138.0, 135.7, 135.7, 133.3, 133.2, 129.83, 129.82, 128.6, 
128.5, 127.8 (2C), 127.6, 123.3 (q, J = 283.5 Hz), 104.5, 92.5 (q, J = 33.4 Hz), 86.0, 83.4, 66.6, 
58.6, 56.6, 27.2, 26.9, 19.4, 18.8, 11.5. 
IR νmax 3070 (w), 2939 (m), 2892 (w), 2863 (m), 2175 (w), 1465 (w), 1428 (w), 1384 (w), 1369 
(w), 1293 (m), 1158 (s), 1110 (s), 1036 (w), 997 (w), 912 (w), 884 (w), 858 (w), 821 (m), 738 
(m). 
HRMS (ESI) calcd for C40F3H55NO2Si2
+ [M+H]+ 694.3718; found 694.3719. 
Stereochemistry was assigned by analogy. 
 
3-(3-Benzyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidin-5-
yl)propanenitrile (9sa) 
Following General Procedure C, the title compound was prepared from 4-
((benzylamino)methyl)pent-4-enenitrile (4s) (60.1 mg, 0.300 mmol) and 
(bromoethynyl)triisopropylsilane (5a) (102 mg, 0.390 mmol, 1.3 eq). 
The crude oil (>20:1 dr determined by integration in the crude 1H NMR) 
was purified by column chromatography (SiO2 3:1 Pentane:CH2Cl2) 
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affording the title compound 9sa (91 mg, 0.19 mmol, 63 % yield, >20:1 dr determined by 1H 
NMR) as a pale yellow oil.  
 
Rf 0.25 (Pentane/CH2Cl2 2/1).  
1H NMR (400 MHz, CDCl3) δ 7.38 – 7.27 (m, 5H, ArH), 4.70 (q, J = 4.4 Hz, 1H, CHCF3), 4.18 
(d, J = 13.0 Hz, 1H, CH2Ph), 3.68 (d, J = 13.0 Hz, 1H, CH2Ph), 3.04 (d, J = 10.4 Hz, 1H, CH2N), 
3.00 (d, J = 10.4 Hz, 1H, CH2N), 2.60 (d, J = 17.1 Hz, 1H, CH2CC), 2.54 (d, J = 17.1 Hz, 1H, 
CH2CC), 2.51 – 2.44 (m, 2H, CH2CN), 2.18 – 2.10 (m, 2H, CH2CH2CN), 1.04 (m, 21H, TIPS).  
13C NMR (101 MHz, CDCl3) δ 137.3, 128.8, 128.6, 127.9, 123.3 (q, J = 283.5 Hz), 119.6, 102.6, 
91.9 (q, J = 33.5 Hz), 84.9, 83.8, 60.0, 57.9, 33.2, 29.5, 18.7, 11.8, 11.3. 
IR νmax 3033 (w), 2945 (m), 2894 (w), 2866 (m), 2253 (w), 2176 (w), 1462 (w), 1380 (w), 1291 
(m), 1163 (s), 1082 (w), 1031 (w), 993 (w), 910 (s), 888 (w), 857 (w), 733 (s). 
HRMS (ESI) calcd for C26F3H38N2OSi
+ [M+H]+ 479.2700; found 479.2696. 
  
Stereochemistry was assigned by 2D ROESY NMR experiment. 
 
 
3-Benzyl-5-(4-methyl-4-((triisopropylsilyl)oxy)pent-2-yn-1-yl)-2-
(trifluoromethyl)oxazolidine (9ab) 
 
Following General Procedure A with cinnamyl(cyclopenta-2,4-
dien-1-yl)palladium (6) (6.9 mg, 0.024 mmol, 8 mol %), DPEPhos 
(7a) (19.4 mg, 0.036 mmol, 12 mol%), the title compound was 
prepared from N-benzylprop-2-en-1-amine (4a) (44.2 mg, 0.300 
mmol) and ((4-bromo-2-methylbut-3-yn-2-
yl)oxy)triisopropylsilane (5b) (125 mg, 0.390 mmol, 1.3 eq). The crude oil (1:1 dr determined by 
integration in the crude 1H NMR) was purified by column chromatography (SiO2 14:1 
Pentane:CH2Cl2) affording the title compound 9ab (101 mg, 0.209 mmol, 70 % yield, 1:1 dr 
determined by integration in the 1H NMR). 
 
Rf 0.60 (Pentane/CH2Cl2 6/1). 
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 1(A):1(B) δ 7.40 – 7.27 (m, 10H, ArH 
A + B), 4.72 – 4.62 (m, 2H, CHCF3, A + B), 4.37 (m, 1H, OCH A), 4.24 (m, 1H, OCH B), 4.18 (d, 
J = 13.2 Hz, 1H, CH2Ph A), 3.99 (d, J = 13.3 Hz, 1H, CH2Ph B), 3.84 (d, J = 13.3 Hz, 1H, CH2Ph 
B), 3.74 (d, J = 13.1 Hz, 1H, CH2Ph A), 3.31 (dd, J = 9.4, 5.6 Hz, 1H, CH2N A), 3.14 – 3.06 (m, 
1H, CH2N B), 3.00 (m, 1H, CH2N B), 2.72 – 2.54 (overlapping signals, 3 m, 3H, CH2CC B, 
CH2N A and CH2CC A), 2.49 – 2.32 (overlapping signals, m, 2H, CH2CC B, CH2CC A), 1.46-
1.45 (overlapping signals, 2 s, 12H, CH3 A and B), 1.15 – 1.01 (m, 42H, TIPS A and B). 
13C NMR (101 MHz, CDCl3) δ 137.8, 137.7, 128.70 (2C), 128.67, 128.6, 127.9 , 127.7, 123.8 (q, 
J = 285 Hz), 123.4 (q, J = 283 Hz), 92.8 (q, J = 33.7 Hz), 91.6 (q, J = 33.2 Hz), 88.3, 88.0, 75.8, 
66.3 (overlapping signals, 2 s), 59.7, 59.3, 56.8, 56.7, 33.5 (overlapping signals), 24.03, 23.97, 
18.4, 13.1. 
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IR νmax  2942 (w), 2895 (w), 2867 (w), 1464 (w), 1379 (w), 1294 (w), 1245 (w), 1166 (s), 1054 
(m), 885 (w), 699 (w). 
HRMS calcd for C26H41F3NO2Si
+ [M+H]+ 484.2853; found 484.2852. 
 
3-Benzyl-5-(4-(benzyloxy)dec-2-yn-1-yl)-5-methyl-2-(trifluoromethyl)oxazolidine (9qc) 
Following General Procedure C with cinnamyl(cyclopenta-2,4-dien-
1-yl)palladium (6) (6.9 mg, 0.024 mmol, 8 mol %), XANTPhos (7b) 
(20.8 mg, 0.036 mmol, 12 mol%), the title compound was prepared 
from N-benzyl-2-methylprop-2-en-1-amine (4q) (48.4 mg, 0.300 
mmol) and (((1-bromonon-1-yn-3-yl)oxy)methyl)benzene (5c) (121 
mg, 0.390 mmol, 1.3 eq). The crude oil was purified by column chromatography (SiO2 8:1 
Pentane:CH2Cl2) affording the title compound 9qc (92 mg, 0.19 mmol, 63% yield, single 
diastereoisomer by crude 19F NMR) as a yellow oil.  
 
Rf 0.20 (Pentane:CH2Cl2 4:1).  
1H NMR (400 MHz, CDCl3) δ 7.42 – 7.27 (m, 10H), 4.80 – 4.72 (overlapping signals, 2 m, 2H, 
CHCF3 and OCH2Ph), 4.49 (m, 1H, OCH2Ph), 4.18 (d, J = 13.3 Hz, 1H, NCH2Ph), 4.09 (t, J = 
6.4 Hz, 1H, OCHCC), 3.80 (d, J = 13.3 Hz, 1H, NCH2Ph), 3.05 (d, J = 10.1 Hz, 1H, NCH2), 2.99 
(d, J = 10.1 Hz, 1H, NCH2), 2.60 (d, J = 17.0 Hz, 1H, CH2CC), 2.58 (d, J = 17.0 Hz, 1H, 
CH2CC), 1.83 – 1.66 (m, 2H, CCCHCH2), 1.53 – 1.40 (overlapping signals, s and m, 5H, 
NCH2CCH3 and CCCHCHCH2), 1.37 – 1.24 (m, 6H, MeCH2CH2CH2), 0.96 – 0.86 (m, 3H, Me). 
13C NMR (101 MHz, CDCl3) δ 138.2, 138.0, 128.63, 128.5, 128.4, 128.0, 127.7, 127.6, 123.6 (q, 
J = 284.1 Hz), 92.2 (q, J = 33.3 Hz), 83.8, 82.2, 81.9, 70.5, 69.0, 60.9, 58.5, 36.1, 31.9, 31.2, 
29.1, 25.5, 25.1, 22.7, 14.2. 
IR νmax 3064 (w), 3032 (w), 2930 (m), 2858 (m), 2250 (w), 1496 (w), 1456 (w), 1379 (w), 1332 
(w), 1293 (m), 1208 (w), 1153 (s), 1094 (s), 1074 (m), 1035 (w), 985 (w), 911 (m), 855 (w), 734 
(s). 
HRMS (ESI) calcd for C29H37F3NO2
+ [M+H]+ 488.2771; found 488.2777. 
Stereochemistry was assigned by analogy. 
 
 
3-Benzyl-5-methyl-2-(trifluoromethyl)-5-(5-(triisopropylsilyl)penta-2,4-diyn-1-
yl)oxazolidine (9qd) 
Following General Procedure C with cinnamyl(cyclopenta-2,4-
dien-1-yl)palladium (6) (6.9 mg, 0.024 mmol, 8 mol %), 
XANTPhos (7b) (20.8 mg, 0.036 mmol, 12 mol%), the title 
compound was prepared from N-benzyl-2-methylprop-2-en-1-
amine (4q) (48.4 mg, 0.300 mmol) and (bromobuta-1,3-diyn-1-
yl)triisopropylsilane (5d) (111 mg, 0.390 mmol, 1.3 eq). The crude oil (7.2:1 dr determined by 
integration in the crude 19F NMR) was purified by column chromatography (SiO2 12:1 
Pentane:CH2Cl2) affording the title compound 9qd (97 mg, 0.21 mmol, 70% yield, 8.3:1 dr 
determined by integration in the 19F NMR) as a pale yellow oil. 
  
Rf 0.60 (Pentane:CH2Cl2 4:1).  
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 8.3(A):1(B) δ 7.40 – 7.27 (m, 10H, 
ArH A + B), 4.75 (q, J = 4.7 Hz, 2H, CHCF3 A + B), 4.17 (d, J = 13.5 Hz, 2H, CH2Ph A + B), 
3.86 (d, J = 13.5 Hz, 1H, CH2Ph A), 3.79 (d, J = 13.2 Hz, 1H, CH2Ph B), 3.08 (d, J = 10.3 Hz, 
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2H, CH2N A + B), 2.96 (d, J = 10.3, 2H, CH2N A + B), 2.66 (d, J = 17.3, 1H, CH2CC A), 2.62 (d, 
J = 17.3, 1H, CH2CC A), 2.61 (d, J = 16.8, 1H, CH2CC B), 2.58 (d, J = 16.8, 1H, CH2CC B), 1.46 
(s, 6H, CH3 A + B), 1.10 (s, 42H, TIPS A + B). 
13C NMR (101 MHz, CDCl3) major diastereomer δ 138.1, 128.7, 128.4, 127.6, 123.5 (q, J = 285 
Hz), 92.2 (q, J = 33 Hz), 89.7, 83.7, 81.6, 74.3, 68.2, 61.1, 58.5, 32.0, 25.4, 18.7, 11.4. 
IR νmax 2944 (m), 2894 (w), 2867 (m), 2226 (w), 2106 (w), 1461 (w), 1381 (w), 1293 (m), 1262 
(w), 1240 (w), 1155 (s), 1100 (m), 1076 (w), 1036 (w), 1025 (w), 995 (w), 917 (w), 883 (w), 855 
(w), 822 (w), 728 (w). 
HRMS (ESI) calcd for C26F3H37NOSi
+ [M+H]+ 464.2591; found 464.2600. 
Stereochemistry was assigned by analogy. 
 
3-Benzyl-5-(2-fluorobenzyl)-2-(trifluoromethyl)oxazolidine (9ae) 
 
Following General Procedure A with cinnamyl(cyclopenta-2,4-dien-1-
yl)palladium (6) (6.9 mg, 0.024 mmol, 8 mol %), DPEPhos (7a) (19 mg, 
0.036 mmol, 12 mol%), the title compound was prepared from N-
benzylprop-2-en-1-amine (4a) (44.2 mg, 0.300 mmol), 1-ethoxy-2,2,2-
trifluoroethanol (3) (0.123 mL, 0.900 mmol, 3.0 eq) and 1-bromo-2-fluorobenzene (5e) (0.066 
ml, 0.60 mmol, 2 eq) at 70 °C. The crude oil (2:1 dr determined by integration in the crude 1H 
NMR) was purified by column chromatography (SiO2 10:1 Pentane:CH2Cl2) affording the title 
compound 9ae (70 mg, 0.21 mmol, 69 % yield, 2:1 dr determined by integration in the 1H NMR) 
as a pale yellow oil. 
 
Rf 0.35 (Pentane:CH2Cl2 4:1).  
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 2(A):1(B) δ 7.39 – 7.17 (m, 14H, ArH 
A + B), 7.10 – 6.96 (m, 4H, ArH A + B), 4.72 – 4.63 (m, 2H, CHCF3 A + B), 4.59 – 4.50 (m, 1H, 
OCH A), 4.44 – 4.34 (m, 1H, OCH B), 4.09 (d, J = 13.2 Hz, 1H, CH2Ph A), 3.95 (d, J = 13.3 Hz, 
1H, CH2Ph B), 3.83 (d, J = 13.3 Hz, 1H, CH2Ph B), 3.64 (d, J = 13.2 Hz, 1H, CH2Ph A), 3.18 (dd, 
J = 9.3, 5.5 Hz, 1H, CH2N A), 3.09 – 2.87 (overlapping signals, m, 6H, CH2N B and CH2Ar A + 
B), 2.53 – 2.43 (m, 1H, CH2N A). 
13C NMR (101 MHz, CDCl3) δ 161.2 (d, J = 245.2 Hz), 161.1 (d, J = 245.4 Hz), 138.0, 137.9, 
131.8 (d, J = 4.7 Hz), 131.6 (d, J = 4.5 Hz), 128.8 – 128.4 (overlapping signals, m), 127.8, 127.6,  
124.6 (d, J = 15.8 Hz), 124.39 – 124.21 (overlapping signals, m), 124.2 (q, J = 284.9 Hz), 124.0 
(d, J = 15.9 Hz), 123.7 (q, J = 283.3 Hz), 115.5 (d, J = 22.3 Hz), 115.4 (d, J = 22.2 Hz), 92.7 (q, J 
= 33.5 Hz), 91.4 (q, J = 33.1 Hz), 79.0, 76.8, 59.9, 59.2, 56.8, 56.6, 33.4, 32.9. 
IR νmax 3085 (w), 3066 (w), 3034 (w), 2935 (w), 2842 (w), 1587 (w), 1494 (m), 1456 (w), 1293 
(m), 1292 (m), 1233 (m), 1163 (s), 1036 (w), 989 (w), 928 (w), 859 (w), 827 (w), 761 (m), 760 
(m), 734 (w). 
HRMS (ESI) calcd for C18H18F4NO
+ [M+H]+ 340.1319; found 340.1315. 
 
3-Benzyl-5-(2-(trifluoromethoxy)benzyl)-2-(trifluoromethyl)oxazolidine (9af) 
 
 Following General Procedure A with cinnamyl(cyclopenta-2,4-dien-1-
yl)palladium (6) (6.9 mg, 0.024 mmol, 8 mol %), DPEPhos (7a) (19 mg, 
0.036 mmol, 12 mol%), the title compound was prepared from N-
benzylprop-2-en-1-amine (4a) (44.2 mg, 0.300 mmol), 1-ethoxy-2,2,2-
trifluoroethanol (3) (0.123 mL, 0.900 mmol, 3.0 eq) and 1-bromo-2-
(trifluoromethoxy)benzene (5f) (0.089 ml, 0.60 mmol, 2 eq) at 70 °C. The crude oil (1.9:1 dr 
determined by integration in the crude 1H NMR) was purified by column chromatography (SiO2 
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10:1 Pentane:CH2Cl2) affording the title compound 9af (81 mg, 0.20 mmol, 67% yield, 1.6:1 dr 
determined by integration in the 1H NMR) as a yellow oil. 
 
Rf 0.40 (Pentane:CH2Cl2 4:1).  
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 1.6(A):1(B) δ 7.38 – 7.21 (m, 18H, 
ArH A + B), 4.73 – 4.65 (m, 2H, CHCF3 A + B), 4.60 – 4.51 (m, 1H, OCH A), 4.43 – 4.34 (m, 
1H, OCH B), 4.13 (d, J = 13.1 Hz, 1H, CH2Ph A), 3.97 (d, J = 13.3 Hz, 1H, CH2Ph B), 3.85 (d, J 
= 13.3 Hz, 1H, CH2Ph B), 3.68 (d, J = 13.1 Hz, 1H, CH2Ph A), 3.20 (dd, J = 9.3, 5.4 Hz, 1H, 
CH2N A), 3.11 – 2.91 (m, 6H, CH2Ar A + B and CH2N B), 2.49 (app t, J = 8.8 Hz, 1H, CH2N A). 
13C NMR (101 MHz, CDCl3) δ 147.9 – 147.7 (m, 2C), 137.9, 137.8, 132.1, 131.6, 130.3, 129.8, 
128.8, 128.7, 128.6, 128.5, 128.3 (2C), 127.8, 127.7, 127.0, 126.9, 124.0 (q, J = 284.8 Hz), 123.5 
(q, J = 283.3 Hz), 120.9 (q, J = 257.5 Hz, 2C), 120.5 (q, J = 1.7 Hz), 120.4 (d, J = 1.6 Hz), 92.8 
(q, J = 33.5 Hz), 91.3 (q, J = 33.2 Hz), 78.9, 76.7, 59.9, 59.2, 56.9, 56.7, 34.3, 33.7. 
IR νmax 3068 (w), 3034 (w), 2932 (w), 2848 (w), 1495 (w), 1455 (w), 1377 (w), 1255 (s), 1221 
(s), 1150 (s), 1047 (w), 1026 (w), 989 (w), 927 (w), 858 (w), 761 (w), 728 (w). 
HRMS (ESI) calcd for C19H18F6NO2
+ [M+H]+ 406.1236; found 406.1230. 
 
 
3-Benzyl-5-(2-chlorobenzyl)-2-(trifluoromethyl)oxazolidine (9ag) 
 
Following General Procedure A with cinnamyl(cyclopenta-2,4-dien-1-
yl)palladium (6) (6.9 mg, 0.024 mmol, 8 mol %), DPEPhos (7a) (19 mg, 
0.036 mmol, 12 mol%), the title compound was prepared from N-
benzylprop-2-en-1-amine (4a) (44.2 mg, 0.300 mmol), 1-ethoxy-2,2,2-trifluoroethanol (3) (0.123 
mL, 0.900 mmol, 3.0 eq) and 1-bromo-2-chlorobenzene (5g) (0.070 mL, 0.60 mmol, 2 eq) at 70 
°C. The crude oil (2:1 dr determined by integration in the crude 1H NMR) was purified by 
column chromatography (SiO2 10:1 Pentane:CH2Cl2) affording the title compound 9ag (69 mg, 
0.19 mmol, 65% yield, 1.9:1 dr determined by integration in the 1H NMR) as a pale yellow oil. 
 
Rf 0.40 (Pentane:CH2Cl2 4:1).  
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 1.9(A):1(B) δ 7.40 – 7.32 (m, 10H, 
ArH A + B), 7.32 – 7.27 (m, 4H, ArH A + B), 7.24 – 7.16 (m, 4H, ArH A + B), 4.73 – 4.67 (m, 
2H, CHCF3 A + B), 4.66 – 4.58 (m, 1H, OCH A), 4.52 – 4.43 (m, 1H, OCH B), 4.13 (d, J = 13.2 
Hz, 1H, CH2Ph A), 3.97 (d, J = 13.4 Hz, 1H, CH2Ph B), 3.86 (d, J = 13.4 Hz, 1H, CH2Ph B), 3.69 
(d, J = 13.2 Hz, 1H, CH2Ph A), 3.25 – 3.14 (m, 2H, CH2N A and CH2Ar A), 3.14 – 2.99 (m, 5H, 
CH2N B and CH2Ar A + B), 2.54 (app t, J = 8.8 Hz, 1H, CH2N A). 
13C NMR (101 MHz, CDCl3) δ 137.9, 137.8, 135.5, 135.0, 134.3, 134.1, 131.8, 131.4, 129.7, 
129.6, 128.7, 128.6, 128.6, 128.5, 128.3 (2C), 127.8, 127.6, 127.1 (2C), 124.0 (q, J = 284.9 Hz), 
123.5 (q, J = 283.3 Hz), 92.7 (q, J = 33.6 Hz), 91.3 (q, J = 33.1 Hz), 78.7, 76.4, 59.9, 59.2, 56.7, 
56.6, 37.7, 37.2. 
IR νmax 3066 (w), 3031 (w), 2934 (w), 2899 (w), 2841 (w), 1476 (w), 1449 (w), 1379 (w), 1342 
(w), 1291 (m), 1145 (s), 1098 (m), 1050 (m), 986 (w), 928 (w), 857 (w), 754 (m), 736 (m). 
HRMS (ESI) calcd for C18H18ClF3NO
+ [M+H]+ 356.1024; found 356.1019. 
 
 
3-benzyl-2-(trifluoromethyl)-5-(3-(trifluoromethyl)benzyl)oxazolidine (9ah) 
 Following General Procedure A with cinnamyl(cyclopenta-2,4-dien-1-
yl)palladium (6) (6.9 mg, 0.024 mmol, 8 mol %), DPEPhos (7a) (19 mg, 
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0.036 mmol, 12 mol%), the title compound was prepared from N-benzylprop-2-en-1-amine (4a) 
(44.2 mg, 0.300 mmol), 1-ethoxy-2,2,2-trifluoroethanol (3) (0.123 mL, 0.900 mmol, 3.0 eq) and 
1-bromo-3-(trifluoromethyl)benzene (5h) (0.084 mL, 0.60 mmol, 2 eq) at 70 °C. The crude oil 
(2.5:1 dr determined by integration in the crude 1H NMR) was purified by column 
chromatography (SiO2 10:1 Pentane:CH2Cl2) affording the title compound 9ah (64 mg, 0.16 
mmol, 55% yield, 2.6:1 dr determined by integration in the 1H NMR) as a pale yellow oil. 
 
Rf 0.40 (Pentane:CH2Cl2 4:1).  
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 2.6(A):1(B) δ 7.54 – 7.24 (m, 18H, 
ArH A + B), 4.75 – 4.63 (m, 2H, CHCF3 A + B), 4.59 – 4.50 (m, 1H, OCH A), 4.39 – 4.29 (m, 
1H, OCH B), 4.08 (d, J = 13.2 Hz, 1H, CH2Ph A), 3.97 (d, J = 13.3 Hz, 1H, CH2Ph B), 3.84 (d, J 
= 13.3 Hz, 1H, CH2Ph B), 3.60 (d, J = 13.2 Hz, 1H, CH2Ph A), 3.18 (dd, J = 9.2, 5.5 Hz, 1H, 
CH2N A), 3.09 – 2.97 (m, 4H, CH2Ar A + B  and CH2N B), 2.92 (dd, J = 14.2, 6.1 Hz, 1H, CH2Ar 
A), 2.85 (dd, J = 13.9, 5.4 Hz, 1H, CH2Ar B), 2.43 (app t, J = 8.9 Hz, 1H, CH2N A). 
13C NMR (101 MHz, CDCl3) δ 138.7, 138.1, 137.8, 137.7, 132.8, 132.7, 131.0 (q, J = 32.2 Hz, 
2C), 129.1, 129.0, 128.7 (2C), 128.6, 128.6, 127.9, 127.7, 126.1 (q, J = 3.7 Hz), 126.0 (q, J = 3.9 
Hz), 124.3 (q, J = 272.2 Hz), 124.2 (q, J = 272.2 Hz), 124.0 (q, J = 284.6 Hz), 123.9 – 123.6 (2 
overlapping q), 123.5 (q, J = 283.1 Hz), 92.8 (q, J = 33.5 Hz), 91.3 (q, J = 33.2 Hz), 79.5, 77.7, 
60.0, 59.0, 56.6, 56.5, 40.0, 39.6.23 
IR νmax 3068 (w), 3034 (w), 2948 (w), 2829 (w), 1695 (w), 1496 (w), 1452 (w), 1332 (s), 1293 
(m), 1164 (s), 1131 (s), 1079 (m), 1026 (w), 918 (w), 859 (w), 803 (w), 733 (w). 
HRMS (ESI) calcd for C19H18F6NO
+ [M+H]+ 390.1287; found 390.1287. 
 
3-Benzyl-5-((3-fluoropyridin-2-yl)methyl)-2-(trifluoromethyl)oxazolidine (9ai) 
 
Following General Procedure A with cinnamyl(cyclopenta-2,4-dien-1-
yl)palladium (6) (6.9 mg, 0.024 mmol, 8 mol %), DPEPhos (7a) (19 mg, 
0.036 mmol, 12 mol%), the title compound was prepared from N-
benzylprop-2-en-1-amine (4a) (44.2 mg, 0.300 mmol), 1-ethoxy-2,2,2-
trifluoroethanol (3) (0.123 mL, 0.900 mmol, 3.0 eq) and 2-bromo-3-
fluoropyridine (5i) (106 mg, 0.600 mmol, 2 eq) at 70 °C. The crude oil (1.4:1 dr determined by 
integration of PhCH2N peaks in the 
1H NMR) was purified by column chromatography (SiO2 
10:1:0.1 Pentane:EtOAc:Et3N) affording the title compound 9ai (95 mg, 0.28 mmol, 93 % yield, 
1.4:1 dr determined by integration of PhCH2N peaks in the 
1H NMR) as a pale yellow oil. 
 
Rf 0.35 (Pentane:EtOAc 4:1).  
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 1.4(A):1(B) 8.34 (m, 2H, ArH A + B), 
7.38 – 7.24 (m, 12H, ArH A + B), 7.17 (m, 2H, ArH A + B), 4.79 – 4.65 (m, 2H, CHCF3 A + B 
and OCH A + B), 4.16 (d, J = 13.2 Hz, 1H, CH2Ph A), 3.97 (d, J = 13.4 Hz, 1H, CH2Ph B), 3.89 
(d, J = 13.4 Hz, 1H, CH2Ph B), 3.75 (d, J = 13.2 Hz, 1H, CH2Ph A), 3.37 (dd, J = 6.4, 2.3 Hz, 1H, 
CH2Ar B), 3.33 (dd, J = 6.2, 2.3 Hz, 1H, CH2Ar A), 3.29 (dd, J = 9.5, 5.5 Hz, 1H, CH2N A), 3.18 
– 2.98 (m, 4H, CH2N B and CH2Ar A + B), 2.61 (app t, J = 8.8 Hz, 1H, CH2N A). 
13C NMR (101 MHz, CDCl3) δ 158.1 (d, J = 256.8 Hz), 158.0 (d, J = 256.8 Hz), 146.3 (d, J = 
15.5 Hz), 145.9 (d, J = 15.3 Hz), 145.2 (d, J = 5.5 Hz), 145.1 (d, J = 5.5 Hz), 138.0, 137.9, 128.7, 
128.6, 128.5, 128.5, 127.7, 127.6, 124.0 (q, J = 284.6 Hz), 123.7 (q, J = 283.2 Hz), 123.3 (d, J = 
3.7 Hz), 123.1 (d, J = 3.7 Hz), 122.9 (d, J = 19.8 Hz), 122.8 (d, J = 19.8 Hz), 92.8 (q, J = 33.7 
Hz), 91.3 (q, J = 33.2 Hz), 78.1, 75.8, 60.0, 59.4, 57.2, 56.7, 36.1, 35.3. 
                                                 
23 Not all signals in 13C NMR could be resolved. 
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IR νmax 3069 (w), 3031 (w), 2936 (w), 2846 (w), 1739 (w), 1603 (w), 1452 (m), 1375 (w), 1340 
(w), 1291 (m), 1250 (m), 1161 (s), 1055 (w), 1036 (w), 985 (w), 914 (w), 857 (w), 804 (w), 732 
(m). 
HRMS (ESI) calcd for C17H17F4N2O
+ [M+H]+ 341.1272; found 341.1276. 
 
3-Benzyl-5-(2-fluorobenzyl)-2-(trifluoromethyl)oxazolidine (9aj) 
 
Following General Procedure A with cinnamyl(cyclopenta-2,4-dien-1-
yl)palladium (6) (6.9 mg, 0.024 mmol, 8 mol %), DPEPhos (7a) (19 mg, 
0.036 mmol, 12 mol%), the title compound was prepared from N-
benzylprop-2-en-1-amine (4a) (44.2 mg, 0.300 mmol), 1-ethoxy-2,2,2-
trifluoroethanol (3) (0.123 mL, 0.900 mmol, 3.0 eq) and 2-bromo-3,3,3-
trifluoroprop-1-ene (5j) (0.085 ml, 0.66 mmol, 2 eq) at 70 °C. The crude oil (>20:1 dr determined 
by integration in the crude 1H NMR) was purified by column chromatography (SiO2 10:1 
Pentane:CH2Cl2) affording the title compound 9aj (70 mg, 0.21 mmol, 69 % yield, >20:1 dr 
determined by integration in the 1H NMR) as a pale yellow oil. 
 
Rf 0.35 (Pentane:CH2Cl2 4:1).  
1H NMR (400 MHz, CDCl3) δ 7.39 – 7.27 (m, 5H, ArH), 4.68 (q, J = 4.9 Hz, 1H, CHCF3), 4.54 
– 4.44 (m, 1H, OCH), 4.19 (d, J = 13.1 Hz, 1H, CH2Ph), 3.72 (d, J = 13.1 Hz, 1H, CH2Ph), 3.27 
(dd, J = 9.1, 5.4 Hz, 1H, CH2N), 2.58 (dd, J = 15.7, 7.6 Hz, 1H, CH2CC), 2.46 – 2.37 
(overlapping signals, 2 m, 2H, CH2N and CH2CC). 
13C NMR (101 MHz, CDCl3) δ 137.7, 134.4 (q, J = 30.3 Hz), 128.7, 128.6, 127.8, 123.9 (d, J = 
284.7 Hz), 123.5 (q, J = 273.3 Hz), 120.6 (q, J = 5.7 Hz), 91.2 (q, J = 33.4 Hz), 77.1, 59.2, 57.1, 
33.6. 
IR νmax 2924 (w), 2853 (w), 1452 (w), 1419 (w), 1372 (w), 1342 (w), 1294 (m), 1170 (s), 1131 
(s), 1036 (w), 951 (w), 857 (w), 731 (w). 
HRMS (ESI) calcd for C15H16F6NO
+ [M+H]+ 340.1131; found 340.1132. 
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5. Products transformations 
1-((4-Methoxybenzyl)amino)-5-(triisopropylsilyl)pent-4-yn-2-ol oxazolidine (10) 
 
 
 
 
 
 
 
 
To a solution of 3-(4-methoxybenzyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-
yl)oxazolidine (9ba) (91 mg, 0.20 mmol, 1.0 eq, 1.1:1 dr) in wet THF (9.0 mL) and Methanol 
(1.0 mL) was added 4-methylbenzenesulfonic acid (241 mg, 1.40 mmol, 7.0 eq). The reaction 
mixture was stirred at 60 °C for 20h, and then cooled down to rt and diluted with CH2Cl2 (20 
mL). The organic layer was washed with aqueous 2 M NaOH solution (2x10 mL), dried over 
MgSO4, filtered and concentrated under reduced pressure. The residue was purified by column 
chromatography (SiO2, CH2Cl2:Methanol:Et3N 100:3:0 to 85:14:1) affording the title compound 
10 as a pale yellow oil (65 mg, 0.17 mmol, 87 % yield). 
 
Rf 0.10 (EtOAc:Et3N 99:1).  
1H NMR (400 MHz, CDCl3) δ 7.24 – 7.19 (m, 2H, ArH), 6.85 – 6.80 (m, 2H, ArH), 3.86 – 3.79 
(m, 1H, OCH), 3.78 – 3.71 (m, 2H, ArCH2), 3.76 (s, 3H, OCH3), 3.02 (br s, 2H, OH and NH), 
2.87 (dd, J = 12.2, 3.4 Hz, 1H, NCH2), 2.65 (dd, J = 12.2, 8.4 Hz, 1H, NCH2), 2.50 (dd, J = 16.8, 
5.4 Hz, 1H, CH2CC), 2.38 (dd, J = 16.8, 7.0 Hz, 1H, CH2CC), 1.05 – 0.94 (m, 21H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 159.1, 131.2, 129.6, 114.1, 104.4, 83.4, 68.1, 55.4, 53.2, 53.1, 
26.6, 18.8, 11.4. 
IR νmax 3374 (w), 3287 (w), 2942 (s), 2898 (m), 2864 (s), 2172 (w), 1613 (w), 1514 (m), 1464 
(m), 1302 (w), 1249 (s), 1178 (w), 1110 (w), 1077 (w), 1036 (m), 913 (w), 884 (m), 823 (w), 735 
(m). 
HRMS (ESI) calcd for C22H38NO2Si
+ [M+H]+ 376.2666; found 376.2666. 
 
2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidine (11) 
 
 
 
 
 
 
 
 
 
Following a slightly modified procedure,24 to a solution of DDQ (54.5 mg, 0.240 mmol, 1.2 eq) 
in CH2Cl2 (0.80 mL) and water (0.050 mL) at 0 °C was slowly added a solution of 3-(4-
methoxybenzyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidine (9ba) (91 
mg, 0.20 mmol, 1.0 eq, 1.1:1 dr) in CH2Cl2 (0.40 ml). The mixture was stirred at rt for 10 h and 
then poured in ice cold water (10 mL) and extracted with CH2Cl2 (2x10 mL). The combined 
organic phase was dried over MgSO4, filtered and concentrated under reduced pressure. The 
                                                 
24 Lehmann, L.; Friebe M.; Brumby T.; Suelzle D.; Platzek J.  (Schering Aktiengesellschaft) WO2004/87656 A1, 
2004. 
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crude residue was purified by preparative TLC (SiO2, Toluene:CH2Cl2 3:2) affording the title 
compound 11 (53 mg, 0.16 mmol, 79% yield, 1.1:1 dr by integration of the OCH peak in the 1H 
NMR) as a colourless oil. 
 
Rf 0.35 (Toluene:CH2Cl2 4:1).  
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 1.1(A):1(B) δ 5.04 (q, J = 5.8 Hz, 1H, 
CHCF3 A), 4.93 (q, J = 5.4 Hz, 1H, CHCF3 B), 4.42 – 4.34 (m, 1H, OCH A), 4.13 – 4.03 (m, 1H, 
OCH B), 3.46 (ddd, J = 12.0, 5.7, 1.4 Hz, 1H, CH2N B), 3.36 – 3.20 (m, 2H, CH2N A), 3.00 – 
2.85  (m, 2H, CH2N B and NH), 2.81 (dd, J = 16.7, 4.7 Hz, 1H, CH2CC B), 2.69 (bs, 1H, NH), 
2.58 (dd, J = 17.1, 5.6 Hz, 1H, CH2CC A), 2.53 – 2.41 (m, 2H, CH2CC A + B), 1.10 – 0.97 (m, 
42H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 123.5 (d, J = 283.6 Hz), 123.3 (d, J = 282.5 Hz), 104.0, 103.1, 
88.7 (d, J = 33.8 Hz), 88.5 (d, J = 34.0 Hz), 83.4, 83.3, 77.7, 76.1, 51.0, 49.7, 26.3, 24.8, 18.7, 
18.7, 11.3.25 
IR νmax 2946 (w), 2896 (w), 2866 (w), 2254 (w), 2171 (w), 1513 (w), 1464 (w), 1383 (w), 1290 
(w), 1251 (w), 1174 (w), 1150 (w), 1119 (w), 1092 (w), 1034 (w), 994 (w), 993 (w), 908 (s), 732 
(s). 
HRMS (ESI) calcd for C16H29F3NOSi
+ [M+H]+ 336.1965; found 336.1967. 
 
 
1-((4-Methoxybenzyl)(2,2,2-trifluoroethyl)amino)-5-(triisopropylsilyl)pent-4-yn-2-ol (12) 
 
 
 
 
 
 
 
 
 
 
Following a slightly modified procedure,26 a 1.0 M solution of DIBAL-H in hexanes (0.59 ml, 
0.59 mmol, 3.0 eq) was added over 20 min into a solution of 3-(4-methoxybenzyl)-2-
(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)oxazolidine (9ba) (91 mg, 0.20 mmol, 
1.0 eq, 1.1:1 dr) in dry toluene (1.5 ml) at -78 °C under nitrogen. The reaction mixture was 
allowed to slowly warm up to -25 °C and stirred at this temperature for 12 h. The reaction was 
quenched by slow addition of EtOAc (2 mL) at -25 °C and then an aqueous solution of Roch salt 
sat. (1.5 mL) at 0 °C and stirred for further 45 min. The mixture was extracted with EtOAc (2x10 
mL). The combined organic phase was dried over MgSO4, filtered and concentrated under 
reduced pressure, affording the pure title compound 12 (86 mg, 0.19 mmol, 95 % yield) as a 
colourless oil, without any further purification. 
 
1H NMR (400 MHz, CDCl3) δ 7.24 – 7.18 (m, 2H, ArH), 6.90 – 6.84 (m, 2H, ArH), 3.86 (d, J = 
13.6 Hz, 1H, CH2Ph), 3.82 – 3.75 (m, 1H, OCH), 3.80 (s, 3H, OCH3), 3.72 (d, J = 13.6 Hz, 1H, 
CH2Ph), 3.16 (qd, J = 9.4, 3.7 Hz, 2H, CH2CF3), 2.98 (dd, J = 13.3, 3.7 Hz, 1H, NCH2), 2.77 – 
2.65 (m, 2H, OH and NCH2), 2.53 (dd, J = 16.8, 5.2 Hz, 1H, CH2CC), 2.38 (dd, J = 16.8, 7.1 Hz, 
1H, CH2CC), 1.12 – 0.92 (m, 21H, TIPS). 
                                                 
25 One TIPS signal did not split. 
26 Kielland, N., Vicente-García, E., Revés, M., Isambert, N., Arévalo, M. J. and Lavilla, R. Adv. Synth. Catal, 2013, 
355, 3273. 
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13C NMR (101 MHz, CDCl3) δ 159.3, 130.3, 129.6, 125.9 (q, J = 281.6 Hz), 114.1, 104.1, 83.6, 
67.2, 60.0, 58.8, 55.3, 54.6 (q, J = 30.2 Hz), 25.9, 18.7, 11.3.  
IR νmax 3525 (w), 3465 (w), 2943 (m), 2898 (w), 2865 (m), 2173 (w), 1613 (w), 1588 (w), 1514 
(m), 1464 (m), 1419 (w), 1377 (w), 1304 (m), 1250 (s), 1176 (m), 1143 (s), 1085 (s), 1036 (s), 
930 (w), 884 (m), 818 (m), 741 (m). 
HRMS (ESI) calcd for C24H39F3NO2Si
+ [M+H]+ 458.2697; found 458.2694. 
 
3-(4-Methoxybenzyl)-5-(prop-2-yn-1-yl)-2-(trifluoromethyl)oxazolidine (13) 
 
 
 
 
 
 
 
To a solution of 3-(4-methoxybenzyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-
yl)oxazolidine (9ba) (0.091 g, 0.20 mmol, 1.0 eq, 1.1:1 dr) in THF (2.2 ml) at rt was added a 1.0 
M solution of TBAF in THF (0.40 ml, 0.40 mmol, 2.0 eq). The reaction mixture was stirred for 
30 min (TLC monitoring). The reaction was quenched by addition of an aqueous solution of 
NH4Cl sat, diluted with diethyl ether (30 mL). The organic phase was washed with brine (2x5 
mL), dried over MgSO4, filtered and concentrated under reduced pressure. The crude residue was 
purified by preparative TLC (SiO2, Heptane:CH2Cl2 1:1) affording the title compound 13 (0.057 
g, 0.19 mmol, 95 % yield, 1.15: 1 dr by integration of the OCH peak in the 1H NMR) as a 
colourless oil. 
  
Rf 0.45 (Pentane:CH2Cl2 1:1).  
1H NMR (400 MHz, CDCl3) mixture of diastereoisomers 1.15(A):1(B) δ 7.30 – 7.23 (m, 4H, 
ArH A + B), 6.91 – 6.85 (m, 4H, ArH A + B), 4.74 – 4.63 (m, 2H, CHCF3  A + B), 4.46 – 4.36 (m, 
1H, OCH B), 4.32 – 4.22 (m, 1H, OCH A), 4.10 (d, J = 12.9 Hz, 1H, CH2Ph B), 3.91 (d, J = 13.0 
Hz, 1H, CH2Ph A), 3.84 – 3.77 (overlapping signals, 7H, CH2Ph A and OCH3 A + B), 3.71 (d, J = 
12.9 Hz, 1H, CH2Ph B), 3.32 (dd, J = 9.5, 5.8 Hz, 1H, CH2N B), 3.15 (ddd, J = 12.0, 5.8, 1.4 Hz, 
1H, CH2N A), 3.01 (ddd, J = 11.8, 8.1, 1.4 Hz, 1H, CH2N A), 2.68 – 2.55 (m, 3H, CH2N B and 
CH2CC A + B), 2.49 (ddd, J = 16.8, 7.0, 2.7 Hz, 1H, CH2CC B), 2.40 (ddd, J = 16.6, 7.9, 2.7 Hz, 
1H, CH2CC A), 2.01 (t, J = 2.7 Hz, 1H, CCH B), 1.99 (t, J = 2.7 Hz, 1H, CCH B). 
13C NMR (101 MHz, CDCl3) δ 159.3, 159.2, 130.0, 129.9, 129.8, 129.6, 123.8 (d, J = 284.8 Hz), 
123.4 (d, J = 283.3 Hz), 114.1, 114.0, 92.7 (q, J = 33.6 Hz), 91.6 (q, J = 33.3 Hz), 79.7, 79.4, 
77.1, 75.5, 70.9, 70.4, 59.1, 58.6, 56.4 (2C), 55.4 (2C), 23.7, 23.7. 
IR νmax 3381 (w), 2943 (m), 2867 (m), 2173 (w), 1613 (w), 1514 (m), 1464 (w), 1250 (s), 1143 
(s), 1087 (m), 1031 (s), 884 (w), 824 (w), 738 (w). 
HRMS (APPI) calcd for  C15H16F3NO2 [M+] 299.1133; found 299.1140. 
 
3-Benzyl-4-methyl-5-(prop-2-yn-1-yl)-2-(trifluoromethyl)oxazolidine (14) 
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To a solution of 3-benzyl-4-methyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-
yl)oxazolidine (9ba) (33 mg, 0.075 mmol, 1.0 eq, 21.8:1.1:1) in THF (0.80 mL) at rt was added 
was added a 1.0 M solution of TBAF in THF (0.15 mL, 0.15 mmol, 2.0 eq). The reaction mixture 
was stirred for 30 min (TLC monitoring). The reaction was quenched by addition of a solution of 
sat. NH4Cl and diluted with diethyl ether (5 mL). The organic layer was washed with brine (2x2 
mL), dried over MgSO4, filtered and concentrated under reduced pressure. The crude residue was 
purified by column chromatography (SiO2, Pentane:CH2Cl2 8:1 to 4:1) affording the title 
compound 14 (19 mg, 0.067 mmol, 89 % yield, 15.6:1 dr by integration of the CHCF3  peak in the 
1H NMR) as a colourless oil. 
 
Rf 0.25 (Pentane:CH2Cl2 4:1).  
1H NMR (400 MHz, CDCl3) main diastereoisomer δ 7.36 – 7.27 (m, 5H, ArH), 4.73 (q, J = 5.0 
Hz, 1H, CHCF3), 4.08 (d, J = 14.0 Hz, 1H, CH2Ph), 3.98 – 3.89 (m, 2H, OCH and CH2Ph), 3.08 
– 2.99 (m, 1H, NCH), 2.58 (ddd, J = 17.1, 5.7, 2.7 Hz, 1H, CH2CC), 2.51 (ddd, J = 17.2, 4.8, 2.7 
Hz, 1H, CH2CC), 2.03 (t, J = 2.7 Hz, 1H, CCH), 1.01 (d, J = 6.1 Hz, 3H, Me). 
13C NMR (101 MHz, CDCl3) δ 13C NMR (101 MHz, CDCl3) δ 137.7, 129.1, 128.5, 127.7, 123.8 
(q, J = 284.7 Hz), 91.4 (q, J = 33.4 Hz), 83.1, 79.3, 71.0, 63.8, 58.0, 22.4, 18.0. 
IR νmax 2944 (m), 2895 (w), 2867 (m), 2180 (w), 1677 (w), 1462 (w), 1384 (w), 1292 (m), 1149 
(s), 1082 (w), 1018 (w), 994 (w), 883 (w), 859 (w), 730 (w). 
HRMS (ESI) calcd for  C15F3H17NO
+ [M+H]+ 284.1257; found 284.1267. 
 
Stereochemistry assigned by ROESY 
 
 
 
 
 
 
 
 
 
 
 
 
6. Spectra of new compounds (1HNMR, 13CNMR, IR) 
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